
<html lang="en"     class="pb-page"  data-request-id="5edc3b3f-ff43-45a2-990f-58672ac43a58"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401902n;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants" /></meta><meta name="dc.Creator" content="Xue Zhi  Zhao" /></meta><meta name="dc.Creator" content="Steven J.  Smith" /></meta><meta name="dc.Creator" content="Mathieu  Métifiot" /></meta><meta name="dc.Creator" content="Barry C.  Johnson" /></meta><meta name="dc.Creator" content="Christophe  Marchand" /></meta><meta name="dc.Creator" content="Yves  Pommier" /></meta><meta name="dc.Creator" content="Stephen H.  Hughes" /></meta><meta name="dc.Creator" content="Terrence R.  Burke, Jr." /></meta><meta name="dc.Description" content="Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (Au..." /></meta><meta name="Description" content="Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (Au..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 10, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401902n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="This article not subject to U.S. Copyright.  Published 2014 by the American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401902n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401902n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401902n" /></link>
        
    
    

<title>Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401902n" /></meta><meta property="og:title" content="Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0007.jpeg" /></meta><meta property="og:description" content="Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (August 2012), which act as IN strand transfer inhibitors (INSTIs), were the first anti-IN drugs to be approved by the FDA. However, the virus develops resistance to both RAL and EVG, and there is extensive cross-resistance to these two drugs. New “2nd-generation” INSTIs are needed that will have greater efficacy against RAL- and EVG-resistant strains of IN. The FDA has recently approved the first second generation INSTI, GSK’s Dolutegravir (DTG) (August 2013). Our current article describes the design, synthesis, and evaluation of a series of 1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides, 1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides, and 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides. This resulted in the identification of noncytotoxic inhibitors that exhibited single digit nanomolar EC50 values against HIV-1 vectors harboring wild-type IN in cell-based assays. Importantly, some of these new inhibitors retain greater antiviral efficacy compared to that of RAL when tested against a panel of IN mutants that included Y143R, N155H, G140S/Q148H, G118R, and E138K/Q148K." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401902n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401902n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401902n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401902n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401902n&amp;href=/doi/10.1021/jm401902n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1573-1582</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401883v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4019178" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xue+Zhi++Zhao">Xue Zhi Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+J.++Smith">Steven J. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathieu++M%C3%A9tifiot">Mathieu Métifiot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+C.++Johnson">Barry C. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Marchand">Christophe Marchand</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Pommier">Yves Pommier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+H.++Hughes">Stephen H. Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrence+R.++Burke%2C++Jr.">Terrence R. Burke, Jr.</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Chemical Biology Laboratory, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">‡</span> <span class="aff-text">HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 301-846-5906. Fax: 301-846-6033. E-mail: <a href="/cdn-cgi/l/email-protection#87e5f2f5ece2f3e2c7efe2ebeeffa9e9eeefa9e0e8f1"><span class="__cf_email__" data-cfemail="d6b4a3a4bdb3a2b396beb3babfaef8b8bfbef8b1b9a0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401902n&amp;href=/doi/10.1021%2Fjm401902n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1573–1582</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 December 2013</li><li><span class="item_label"><b>Published</b> online</span>10 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401902n" title="DOI URL">https://doi.org/10.1021/jm401902n</a></div><div class="article_header-article-copyright"><strong>Copyright © This article not subject to U.S. Copyright.  Published 2014 by the American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401902n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1934</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401902n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xue&quot;,&quot;last_name&quot;:&quot;Zhi Zhao&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;J. Smith&quot;},{&quot;first_name&quot;:&quot;Mathieu&quot;,&quot;last_name&quot;:&quot;Métifiot&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;C. Johnson&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Marchand&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Pommier&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;H. Hughes&quot;},{&quot;first_name&quot;:&quot;Terrence&quot;,&quot;last_name&quot;:&quot;R. Burke&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1573-1582&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401902n&quot;},&quot;abstract&quot;:&quot;Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (August 2012), which act as IN strand transfer inhibitors (INSTIs), were the first anti-IN drugs to be approved by the FDA. However, the virus develops resistance to both RAL and EVG, and there is extensive cross-resistance to these two drugs. New “2nd-generation” INSTIs are needed that will have greater efficacy against RAL- and EVG-resistant strains of IN. The FDA has recently approved the first second generation INSTI, GSK’s Dolutegravir (DTG) (August 2013). Our current article describes the design, synthesis, and evaluation of a series of 1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides, 1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides, and 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides. This resulted in the identification of noncytotoxic inhibitors that exhibited single digit n&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401902n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401902n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401902n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401902n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401902n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401902n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401902n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401902n&amp;href=/doi/10.1021/jm401902n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401902n" /></input><a href="/doi/pdf/10.1021/jm401902n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (550 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401902n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401902n%26sid%3Dliteratum%253Aachs%26pmid%3D24471816%26genre%3Darticle%26aulast%3DZhao%26date%3D2014%26atitle%3DBicyclic%2B1-Hydroxy-2-oxo-1%252C2-dihydropyridine-3-carboxamide-Containing%2BHIV-1%2BIntegrase%2BInhibitors%2BHaving%2BHigh%2BAntiviral%2BPotency%2Bagainst%2BCells%2BHarboring%2BRaltegravir-Resistant%2BIntegrase%2BMutants%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D4%26spage%3D1573%26epage%3D1582%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jmcmar.2014.57.issue-4/production/jmcmar.2014.57.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Integrase (IN) inhibitors are the newest class of antiretroviral agents developed for the treatment of HIV-1 infections. Merck’s Raltegravir (RAL) (October 2007) and Gilead’s Elvitegravir (EVG) (August 2012), which act as IN strand transfer inhibitors (INSTIs), were the first anti-IN drugs to be approved by the FDA. However, the virus develops resistance to both RAL and EVG, and there is extensive cross-resistance to these two drugs. New “2nd-generation” INSTIs are needed that will have greater efficacy against RAL- and EVG-resistant strains of IN. The FDA has recently approved the first second generation INSTI, GSK’s Dolutegravir (DTG) (August 2013). Our current article describes the design, synthesis, and evaluation of a series of 1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides, 1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides, and 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides. This resulted in the identification of noncytotoxic inhibitors that exhibited single digit nanomolar EC<sub>50</sub> values against HIV-1 vectors harboring wild-type IN in cell-based assays. Importantly, some of these new inhibitors retain greater antiviral efficacy compared to that of RAL when tested against a panel of IN mutants that included Y143R, N155H, G140S/Q148H, G118R, and E138K/Q148K.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">After 30 years of intensive research, approximately 30 drugs have been approved for the treatment of acquired immunodeficiency syndrome (AIDS).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Of these, integrase (IN) inhibitors are the newest drug class<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> with Merck’s Raltegravir (RAL, <b>1</b>) (October 2007)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and Gilead’s Elvitegravir (EVG, <b>2</b>) (August 2012)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> being the first IN inhibitors to be approved by the FDA (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). These agents selectively block the strand transfer step (ST) of the integration reaction as compared with the 3′-processing step (3′-P). For this reason, these drugs are called IN strand transfer inhibitors (INSTIs).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> INSTIs, including RAL and EVG, share key structural features. These include a coplanar arrangement of three heteroatoms, whose function is to chelate the two catalytically important Mg<sup>2+</sup> ions at the IN active site, which are held in place by a conserved DDE motif (D64, D116, and E152 in HIV-1 IN).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Additionally, a halobenzyl ring is present that interacts with the penultimate cytosine base near the 3′-end of the viral DNA. This displaces the dA at the very 3′-end of the viral DNA and in so doing prevents the insertion of the viral DNA into the host genome.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Treatment with RAL and EVG can lead to the development of resistance, and there is extensive shared cross-resistance.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Therefore, “2nd-generation” INSTIs are being developed that have greater efficacies against RAL and EVG-resistant strains of IN.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> GSK’s Dolutegravir (DTG, <b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a second-generation INSTI that has recently received FDA approval for the treatment of AIDS.<a onclick="showRef(event, 'ref1 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref12 ref13">(1, 12, 13)</a> However, the finding that DTG, like all anti-HIV drugs, selects for resistant viruses,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> emphasizes the continuing need to develop INSTIs that can effectively inhibit HIV strains that carry the common/extant resistance mutations.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HIV-1 integrase inhibitors discussed in the text. Mg<sup>2+</sup>-chelating heteroatoms are shown in red with the halogen-substituted aromatic functionality shown in blue. The amide linkers are shown in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An attractive property of DTG is its ability to maintain high potencies against mutant strains of HIV that are resistant to RAL and EVG.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Although DTG contains key structural features that are found in other INSTIs (outlined above and highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), it differs in having its halobenzyl group appended via an amide carbonyl that is proximal to but not part of the triad of metal chelating heteroatoms. This is in contrast to RAL and several other INSTIs, in which the halobenzyl amide carbonyl serves as one of the metal-chelating elements in the heteroatom triad. As a result, the halobenzyl linker moiety of DTG has greater flexibility than RAL structurally related INSTIs. This flexibility may contribute to DTG’s ability to bind tightly to both wild-type (WT) and mutant IN–DNA complexes.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> While differing in their halobenzyl linker arrangements, both RAL and DTG have a hydroxyl group as the central component of their metal-chelating triad of heteroatoms. We noted that hydroxyl amides can function as high affinity metal-chelating groups.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In fact, hydroxylamide-containing INSTIs (for example <b>4</b>) have been reported, which combine a centrally located hydroxylamide metal chelating functionality with flexible halobenzylamide group like the one in DTG.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24">(20-24)</a> Alternatively, inhibitors such as <b>5</b> employ a hydroxylamide group as the terminal member of the metal-chelating triad, and the halobenzyl group is appended through a 1<i>H</i>-pyrrole ring (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Our current report describes new INSTIs (<b>6</b>–<b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) that have a hydroxylamide group as the central component of a triad of metal-chelating heteroatoms, which originate from within bicyclic frameworks. Importantly, the halobenzylamide moieties of many of these inhibitors are appended in a fashion that may not require participation of their amide carbonyls in metal chelation. These inhibitors exhibit high potencies against viral vectors that carry WT IN and the major RAL-resistant IN mutants.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Inhibitor Design</h3><div class="NLM_p last">In designing the current series of inhibitors, we examined two classes of bicyclic platforms that differed in their presentation of the “left” terminal member of the metal-chelating heteroatom triad. Both of these platforms utilized a 1-hydroxypyridin-2(1<i>H</i>)-one moiety as the central and “right” members of the heteroatom triad. However, one class of inhibitor utilized a phenolic hydroxyl as the “left” terminal metal-chelating heteroatom [1,8-dihydroxyquinolin-2(1<i>H</i>)-ones <b>6</b>], while the second class employed a ring-embedded nitrogen to give 1-hydroxy-1,8-naphthyridine-2(<i>1H</i>)-ones (<b>7</b>). The latter class of inhibitors was also varied by the introduction of a 4-hydroxyl substituent [1,4-dihydroxy-1,8-naphthyridine-2(<i>1H</i>)-ones <b>8</b>] (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Three different halogen-substituted benzylamides were examined at the 3-position of the “right” 1-hydroxypyridin-2(1<i>H</i>)-one ring because the nature and pattern of halogen phenyl substitution is known to significantly affect the IN inhibitory potency of INSTIs.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">Modification of a previously reported<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> low-yield Knoevenagel condensation of <i>o</i>-nitrobenzaldehyde <b>9a</b> with diethyl malonate using microwave radiation and a solvent mixture that included benzene provided dimethyl 2-(2-nitrobenzylidene)malonate <b>10a</b> in quantitative yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Treatment of 3-methoxy-2-nitrobenzaldehyde <b>9b</b> with diethyl malonate under similar conditions but without the inclusion of benzene gave the corresponding diethyl 2-(3-methoxy-2-nitrobenzylidene)malonate <b>10b</b> in 90% yield. Initial hydrogenation of <b>10a</b> (0.15 equiv of platinum(IV) oxide) using previously reported conditions that did not contain DMSO,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> provided a very low yield of the desired methyl 1-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate <b>11a</b>, accompanied by significant reduction of the C3–C4 double bond and the <i>N</i>-hydroxyl group. However, when the reduction was performed on <b>10b</b> with the inclusion of DMSO (1.6 equiv),<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> the desired ethyl 1-hydroxy-8-methoxy-2-oxo-1,2-dihydroquinoline-3-carboxylate <b>11b</b> was obtained in 82% yield. In choosing the composition and pattern of halogen substitution on the benzyl amide group, we selected 3′-chloro-4′-fluorobenzyl <b>13a</b> and 3′,4′-difluorobenzyl <b>13b</b>, respectively, based on our previous findings that these can provide improved IN inhibitory potencies.<a onclick="showRef(event, 'ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref31">(26, 31)</a> In addition, we prepared the 2′,4′-difluorobenzyl-substituted pattern <b>12c</b> and <b>13c</b> found in DTG. Demethylation of <b>13a</b>–<b>c</b> with boron tribromide gave the desired final products 1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides, <b>6a</b>–<b>c</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Analogues <b>6a</b>–<b>c</b> and <b>12c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HOAc (4 equiv), CH<sub>2</sub>(CO<sub>2</sub>Me)<sub>2</sub> or CH<sub>2</sub>(CO<sub>2</sub>Et)<sub>2</sub> (12 equiv), piperidine (1.2 equiv), microwave, 80 °C; (ii) H<sub>2</sub>, PtO<sub>2</sub> (0.15 equiv), rt; (iii) 3-Cl-4-F-BnNH<sub>2</sub> (a), 3,4-diF-BnNH<sub>2</sub> (b) or 2,4-diF-BnNH<sub>2</sub> (c), 60 °C; iv) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">Because DTG is unsubstituted at the position para to its central metal-chelating hydroxyl group (the 2-position of its 5-hydroxy-4-oxo-1,3-dihydropyridine-3-carboxamide moiety), we prepared a series of 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>7</b>), which lack a substituent at the corresponding position. Accordingly, in a fashion similar to reported methology,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> treatment of commercially available methyl 2-fluoronicotinate <b>14</b> with benzoxylamine in DMSO followed by acylation of the resulting methyl 2-((benzyloxy)amino)nicotinate with methyl 3-chloro-3-oxopropanoate gave the intermediate methyl 2-(<i>N</i>-(benzyloxy)-3-methoxy-3-oxopropanamido)nicotinate <b>15</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). This was treated with sodium methoxide in methanol to yield the cyclized product, methyl 1-(benzyloxy)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate <b>16</b> (66% yield for three steps from <b>14</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Removal of the 4-hydroxy group was achieved by conversion of <b>16</b> to its triflate <b>17</b> followed by reduction, and the resulting methyl 1-(benzyloxy)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate <b>18</b> was reacted individually with neat 3-chloro-4-fluorobenzylamine (<b>a</b>), 3,4-difluorobenzylamine (<b>b</b>) and 2,4-difluorobenzylamine (<b>c</b>) to provide the corresponding amides <b>19a</b>–<b>c</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Finally, hydrogenolytic deprotection of the <i>N</i>-hydroxyl group gave the desired 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides, (<b>7a</b>–<b>c</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Alternatively, debenzylation of <b>16</b> followed by treatment with halobenzylamines (<b>a</b>, <b>b</b>, and <b>c</b>) in DMF afforded the desired 1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>8a</b>–<b>c</b> along with over-reduced 4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>20a</b>–<b>c</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>7a</b>–<b>c</b> and <b>8a</b>–<b>c</b> and Over-reduced Products <b>20a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnONH<sub>2</sub>, DMSO, 140 °C; (ii) ClCOCH<sub>2</sub>CO<sub>2</sub>CH<sub>3</sub>, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (iii) NaOMe, MeOH, rt; (iv) Tf<sub>2</sub>O, 0 °C; (v) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, TIS, NEt<sub>3</sub>, 85 °C; (vi) (a) 3-Cl-4-F-BnNH<sub>2</sub>, (b) 3,4-diF-BnNH<sub>2</sub>, or (c) 2,4-diF-BnNH<sub>2</sub>; (vii) H<sub>2</sub>, Pd·C.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Evaluation in <i>in Vitro</i> IN Biochemical Assays</h3><div class="NLM_p">Compounds were evaluated in an IN biochemical assay using radiolabeled oligonucleotides to measure the ability of the compounds to inhibit the 3′-P and ST reactions.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> For the 1,8-dihydroxyquinolin-2(1<i>H</i>)-ones (<b>6</b>), 3′-P reactions were inhibited with IC<sub>50</sub> values in the micromolar range, with the 3′-Cl-4′-F and 3′,4′-diF-substituted amides (<b>6a</b>, 3′-P IC<sub>50</sub> = 17 μM; and <b>6b</b>, 3′-P IC<sub>50</sub> = 24 μM) being slightly more potent than the 2′,4′-disubstituted analogue <b>6c</b> (3′-P IC<sub>50</sub> = 43 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These results are consistent with our previous reports that among the diverse halogen substituent patterns we tested, 3-chloro-4-fluoro benzylamides show the best potencies in <i>in vitro</i> assays.<a onclick="showRef(event, 'ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref31">(26, 31)</a> Selectivity for the ST reaction relative to the 3′-P reaction is a defining characteristic of INSTIs, and in the case of <b>6a</b> and <b>6b</b>, selectivity was approximately 30-fold (ST IC<sub>50</sub> values of 0.53 μM and 0.78 μM, respectively; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In contrast, for <b>6c</b> the ST inhibitory potency (ST IC<sub>50</sub> = 18 μM) was very similar to its 3′-P inhibitory potency. There was approximately a 20-fold loss of ST inhibitory potency in going from the 3′,4′-diF to the 2′,4′-diF benzylamide substituent pattern. With the latter pattern of halogen substituents, removal of the 8-hydroxy group abrogated 3′-P inhibitory potency (<b>12c</b>, 3′-P IC<sub>50</sub> >333 μM) but had little effect on ST inhibitory potency (<b>12c</b> ST IC<sub>50</sub> = 19.7 μM). Insertion of a bulky methoxyl group at the 8-position (<b>13c</b>) also abrogated both 3′-P and ST inhibitory potencies (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Potencies of 1,8-Dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides <b>6(a–c)</b> and 1-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides <b>12c</b> and <b>13c</b> Using an <i>in Vitro</i> IN Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> values (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">3′-processing</th><th class="colsep0 rowsep0" align="center">strand transfer</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">3′-Cl-4′-F</td><td class="colsep0 rowsep0" align="left">17 ± 1</td><td class="colsep0 rowsep0" align="left">0.53 ± 0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">3′, 4′-diF</td><td class="colsep0 rowsep0" align="left">24 ± 3</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">43 ± 5</td><td class="colsep0 rowsep0" align="left">18 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">>333</td><td class="colsep0 rowsep0" align="left">19.7 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">>333</td><td class="colsep0 rowsep0" align="left">>333</td></tr></tbody></table></div></div><div class="NLM_p">Using the <i>in vitro</i> IN catalytic assay described above, we showed that compounds <b>7a</b> and <b>7b</b> exhibited potent ST inhibition, with IC<sub>50</sub> values (14 nM and 17 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These were approximately 40-fold lower than the IC<sub>50</sub> values measured for the corresponding 8-dihydroxyquinolin-2(1<i>H</i>)-ones (<b>6a</b> and <b>6b</b>, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>); however, high selectivity for inhibiting the ST reaction versus the 3′-P reaction was maintained. Unexpectedly, compound <b>7c</b>, which contains the benzyl 2′,4′-diF pattern found with DTG, while being slightly less potent (2-fold) than either the 3′-Cl-4′-F or 3′,4′-diF containing compounds (<b>7a</b> and <b>7b</b>, respectively), exhibited a greater than 400-fold enhancement of ST inhibitory potency (IC<sub>50</sub> ≈ 40 nM) relative to the corresponding 8-dihydroxyquinolin-2(1<i>H</i>)-one (<b>6c</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Potencies of 1-Hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>7(a–c)</b> Using an <i>in Vitro</i> IN Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> values (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">3′-processing</th><th class="colsep0 rowsep0" align="center">strand transfer</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">3′-Cl-4′-F</td><td class="colsep0 rowsep0" align="left">9.4 ± 1.5</td><td class="colsep0 rowsep0" align="left">0.014 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">3′, 4′-diF</td><td class="colsep0 rowsep0" align="left">13.6 ± 1.8</td><td class="colsep0 rowsep0" align="left">0.017 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">6.1 ± 0.8</td><td class="colsep0 rowsep0" align="left">0.041 ± 0.012</td></tr></tbody></table></div></div><div class="NLM_p">Given the potentially important role of the carboxamide linker arrangement in DTG’s ability to maintain efficacy against RAL- and EVG-resistant strains of mutant IN,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> we inserted a hydroxyl group at the 4-position of the 1-hydroxy-1,8-naphthyridine-2(<i>1H</i>)-one ring system to ask whether this could potentially influence the inhibitory profiles by hydrogen bonding with the 3-carboxamide carbonyl. However, this modification resulted in a slight loss of ST inhibitory potencies (<b>8a</b>–<b>c</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We also showed that removing the hydroxylamide group resulted in a more than two-orders of magnitude loss of ST inhibitory potency (<b>20a</b>–<b>c</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This is consistent with the important role this hydroxyl may play as the central component of the metal-chelating triad.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Potencies of 1,4-Dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>8(a–c)</b> and 4-Dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>20(a–c)</b> Using an <i>in Vitro</i> IN Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0006.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> values (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">3′-processing</th><th class="colsep0 rowsep0" align="center">strand transfer</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">3′-Cl-4′-F</td><td class="colsep0 rowsep0" align="left">4.7 ± 0.7</td><td class="colsep0 rowsep0" align="left">0.027 ± 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">3′, 4′-diF</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.6</td><td class="colsep0 rowsep0" align="left">0.040 ± 0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.055 ± 0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3′-Cl-4′-F</td><td class="colsep0 rowsep0" align="left">125 ± 15</td><td class="colsep0 rowsep0" align="left">7.8 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3′, 4′-diF</td><td class="colsep0 rowsep0" align="left">93 ± 8</td><td class="colsep0 rowsep0" align="left">8.1 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2′, 4′-diF</td><td class="colsep0 rowsep0" align="left">>333</td><td class="colsep0 rowsep0" align="left">7.1 ± 1.8</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Evaluation of the Compounds in Cell-Based Antiviral Assays</h3><div class="NLM_p">A primary objective in developing second-generation IN inhibitors is to overcome mutations that are associated with resistance to first-generation inhibitors, such as RAL. To determine the abilities of our current inhibitors to retain efficacy against resistant variants, we evaluated the antiviral potencies in cells infected with one-round HIV-1 vectors that carry mutations that cause resistance to RAL (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref10 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref10 ref34 ref35">(10, 34, 35)</a> In these assays, RAL (<b>1</b>) exhibited an EC<sub>50</sub> value (effective concentration resulting in 50% reduction of luciferase reporter signal) of 4 nM in cells infected with virus containing WT IN. Cells infected with viruses containing either the Y143R or the N155H mutant forms of IN, showed significantly elevated EC<sub>50</sub> values (162 nM and 154 nM, respectively). An even greater loss of efficacy (EC<sub>50</sub> = 1900 nM) was observed with viruses containing the G140S/Q148H double mutant form of IN (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In similar assays, treatment of WT-infected cells with inhibitors <b>7a</b>–<b>c</b> and <b>8a</b>–<b>c</b> gave EC<sub>50</sub> values in the low nanomolar range, with analogues <b>7c</b> and <b>8c</b> having the 2′,4′-diF substituted benzyl group (EC<sub>50</sub> values of 5 nM and 6 nM, respectively) showing greater efficacy by several fold relative to analogues having either 3′-Cl-4′-F (<b>7a</b> and <b>8a</b>) or 3′,4′-diF (<b>7b</b> and <b>8b</b>) substituted benzyl groups. This is in contrast to <i>in vitro</i> assays, where analogues bearing the 2′,4′-diF-substituted benzyl group were slightly less effective ST inhibition (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiviral Potencies of Compounds <b>7(a–c)</b> and <b>8(a–c)</b> in Cells Infected with HIV-1 Vectors Containing Wild-Type (WT) or Mutant IN</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">EC<sub>50</sub> (nM, IN mutants<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a>)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM) WT<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Y143R</th><th class="colsep0 rowsep0" align="center">N155H</th><th class="colsep0 rowsep0" align="center">G140S/Q148H</th><th class="colsep0 rowsep0" align="center">SI<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">4 ± 2</td><td class="colsep0 rowsep0" align="left">162 ± 16</td><td class="colsep0 rowsep0" align="left">154 ± 33</td><td class="colsep0 rowsep0" align="left">1900 ± 300</td><td class="colsep0 rowsep0" align="left">>25,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">38 ± 15</td><td class="colsep0 rowsep0" align="left">34 ± 6</td><td class="colsep0 rowsep0" align="left">90 ± 6</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>6,579</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">62 ± 14</td><td class="colsep0 rowsep0" align="left">40 ± 13</td><td class="colsep0 rowsep0" align="left">2200 ± 61</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>4,032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">5.1 ± 1.9</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.8</td><td class="colsep0 rowsep0" align="left">134 ± 23</td><td class="colsep0 rowsep0" align="left">438 ± 121</td><td class="colsep0 rowsep0" align="left">>49,020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">102 ± 18</td><td class="colsep0 rowsep0" align="left">35 ± 12</td><td class="colsep0 rowsep0" align="left">54 ± 9</td><td class="colsep0 rowsep0" align="left">148 ± 8</td><td class="colsep0 rowsep0" align="left">489 ± 62</td><td class="colsep0 rowsep0" align="left">2,914</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">192 ± 19</td><td class="colsep0 rowsep0" align="left">20 ± 6</td><td class="colsep0 rowsep0" align="left">45 ± 12</td><td class="colsep0 rowsep0" align="left">189 ± 70</td><td class="colsep0 rowsep0" align="left">507 ± 125</td><td class="colsep0 rowsep0" align="left">9,600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">137 ± 20</td><td class="colsep0 rowsep0" align="left">6.2 ± 2.9</td><td class="colsep0 rowsep0" align="left">11 ± 2</td><td class="colsep0 rowsep0" align="left">31 ± 8</td><td class="colsep0 rowsep0" align="left">308 ± 125</td><td class="colsep0 rowsep0" align="left">22,097</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Cytotoxic concentration resulting in 50% reduction in the level of ATP in human osteosarcoma (HOS) cells.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Values obtained from cells infected with the lentiviral vector harboring WT IN.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Cells were infected with viral vectors carrying IN mutations and indicated values in EC<sub>50</sub>.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Selectivity index calculated as the ratio of CC<sub>50</sub> to EC<sub>50</sub>.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Not available.</p></div></div></div><div class="NLM_p">An important feature of the new inhibitors is their ability to maintain high efficacies against RAL-resistant strains. For example, compound <b>7c</b> exhibits single digit nanomolar antiviral potencies against both WT and the Y143R mutant, while showing a lower potency against the G140S/Q148H mutant (EC<sub>50</sub> = 438 nM). However, it is much improved when compared to RAL (<b>1</b>) (EC<sub>50</sub> = 1900 nM). Compound <b>8c</b> also retains good efficacy against the Y143R mutant (EC<sub>50</sub> = 11 nM) as well as both the N155H mutant (EC<sub>50</sub> = 31 nM; RAL has EC<sub>50</sub> = 154 nM) and the G140S/Q148H mutant (EC<sub>50</sub> = 308 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p">While showing nanomolar EC<sub>50</sub> values against cells infected with HIV-1 vectors carrying WT and efficacy against some RAL-resistant mutants, analogues <b>7a</b>–<b>c</b> exhibited very little cytotoxicity, with CC<sub>50</sub> values (cytotoxic concentrations were measured as the level of the compound that reduced cellular ATP levels by 50%) greater than 250 μM. In particular, for the 2′,4′-difluorobenzyl amide <b>7c</b> with an EC<sub>50</sub> value of 5.1 nM against WT, this gives a selectivity index (SI = CC<sub>50</sub>/EC<sub>50</sub>) greater than 49,000 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Analogues <b>8a</b>–<b>c</b> showed CC<sub>50</sub> values between approximately 100 μM (<b>8a</b>) and 200 μM (<b>8b</b>). In the case of <b>8c</b>, which showed a WT EC<sub>50</sub> value of 6.2 nM, a SI value greater than 20,000 was achieved.</div><div class="NLM_p">Because compounds <b>7c</b> and <b>8c</b> show antiviral potencies similar to those of RAL (<b>1</b>) against HIV-1 vectors carrying WT IN, it is important to compare the relative effectiveness of our inhibitors against mutant strains of IN in terms of fold-loss relative to WT. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> contains data showing the efficacy of compounds against the G118R and E138K/Q148K mutants, which have recently been identified through <i>in vitro</i> selection studies with second-generation inhibitors.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Of particular note is the ability of <b>8c</b> to maintain efficacy equivalent to that of RAL against the G118R mutant while showing approximately one order of magnitude greater efficacy than RAL against the remaining mutants in the table.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Fold Change (FC) of Amides <b>7c</b> and <b>8c</b> Compared with That of RAL (<b>1</b>) in Cells Infected with HIV-1 Constructs Carrying WT or Mutant IN</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">EC<sub>50</sub> (FC, IN mutants<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM) WT<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Y143R</th><th class="colsep0 rowsep0" align="center">N155H</th><th class="colsep0 rowsep0" align="center">G140S/Q148H</th><th class="colsep0 rowsep0" align="center">G118R</th><th class="colsep0 rowsep0" align="center">E138K/Q148K</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">4 ± 2</td><td class="colsep0 rowsep0" align="left">41× </td><td class="colsep0 rowsep0" align="left">38× </td><td class="colsep0 rowsep0" align="left">475× </td><td class="colsep0 rowsep0" align="left">9× </td><td class="colsep0 rowsep0" align="left">375× </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">5.1 ± 1.9</td><td class="colsep0 rowsep0" align="left">1× </td><td class="colsep0 rowsep0" align="left">26× </td><td class="colsep0 rowsep0" align="left">86× </td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">6.2 ± 2.9</td><td class="colsep0 rowsep0" align="left">2× </td><td class="colsep0 rowsep0" align="left">5× </td><td class="colsep0 rowsep0" align="left">50× </td><td class="colsep0 rowsep0" align="left">6× </td><td class="colsep0 rowsep0" align="left">32× </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values obtained from cells infected with a lentiviral vector harboring WT IN.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Cells were infected with viral constructs carrying IN mutations, and the indicated values correspond to the fold-change (FC) in EC<sub>50</sub> relative to WT.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Not available.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of bicyclic inhibitors were prepared that employed 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>7</b>) and 1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>8</b>) ring systems. Key features of these inhibitors include the use of a hydroxylamide group as a metal-chelating component and the inclusion of halobenzylamide functionality that is appended through a linker whose carboxamide carbonyl is not an obligatory component of the key metal-chelating heteroatom triad. Among these IN inhibitors, amides <b>7c</b> and <b>8c</b> have single digital nanomolar antiviral EC<sub>50</sub> potencies against HIV-1 vectors carrying WT IN. Several compounds have selectivity indices of greater than 20,000, and certain of these inhibitors have greater antiviral efficacies than RAL against a panel of IN mutants that included Y143R, N155H, G118R, and the double mutants G140S/Q148H and E138K/Q148K. Compounds <b>7c</b> and <b>8c</b> represent potentially useful platforms for further structural variations intended to find compounds that are more broadly effective against additional resistant strains of the virus.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Synthesis</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR data were obtained on a Varian 400 MHz spectrometer or a Varian 500 MHz spectrometer and are reported in ppm relative to TMS and referenced to the solvent in which the spectra were collected. The solvent was removed by rotary evaporation under reduced pressure, and anhydrous solvents were obtained commercially and used without further drying. Purification by silica gel chromatography was performed using CombiFlash R<sub>f</sub> 200i with EtOAc–hexanes solvent systems. Preparative high pressure liquid chromatography (HPLC) was conducted using a Waters Prep LC4000 system having photodiode array detection and Phenomenex C<sub>18</sub> columns (Cat. No. 00G-4436-P0-AX, 250 mm × 21.2 mm, 10 μm particle size, 110 Å pore) at a flow rate of 10 mL/min. Binary solvent systems consisting of A = 0.1% aqueous TFA and B = 0.1% TFA in acetonitrile were employed with gradients as indicated. Products were obtained as amorphous solids following lyophilization. Electrospray ionization-mass spectra (ESI-MS) were acquired with an Agilent LC/MSD system equipped with a multimode ion source. Purities of samples subjected to biological testing were assessed using this system and shown to be ≥95%. High-resolution mass spectra (HRMS) were acquired by LC/MS-ESI using an LTQ-Orbitrap-XL at 30K resolution.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure A for the Synthesis of Diethyl 2-(2-(Nitrobenzylidene)malonates (<b>10a</b> and <b>10b</b>)</h3><div class="NLM_p">Commercially available 2-nitrobenzaldehydes (<b>9a</b> and <b>9b</b>) (5 mmol) were added to a solution of dimethyl malonate or diethyl malonate (60 mmol), acetic acid (20 mmol), and piperidine (6 mmol). The mixture was irradiated with microwave radiation with stirring (80 °C, 15 h). The mixture was partitioned between EtOAc (60 mL) and aqueous NaHCO<sub>3</sub> (30 mL), and the organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and filtered, and the filtrate was concentrated. The resulting residue was purified by Combiflash silica gel chromatography (hexanes and EtOAc) to yield either dimethyl (<b>10a</b>) or diethyl 2-(2-nitrobenzylidene)malonate (<b>10b</b>).</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Dimethyl 2-(2-Nitrobenzylidene)malonate (<b>10a</b>)</h4><div class="NLM_p last">Reaction of commercially available 2-nitrobenzaldehyde (<b>9a</b>) and dimethyl malonate in benzene (8 mL) as described in general procedure A with the inclusion of benzene (8.0 mL) provided <b>10a</b> as a colorless oil in 100% yield. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.19 (t, <i>J</i> = 4.1 Hz, 2H), 7.64 (t, <i>J</i> = 7.6 Hz, 1H), 7.56 (t, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 3.85 (s, 3H), 3.59 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 165.24, 163.68, 147.04, 141.73, 133.88, 130.36, 130.24, 129.92, 128.38, 125.06, 52.83, 52.42. ESI-MS <i>m</i>/<i>z</i>: 266.0 (M+H<sup>+</sup>).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Diethyl 2-(3-Methoxy-2-nitrobenzylidene)malonate (<b>10b</b>)</h4><div class="NLM_p last">Reaction of commercially available 3-methoxy-2-nitrobenzaldehyde (<b>9b</b>) and diethyl malonate as described in general procedure A, provided <b>10b</b> as a colorless oil in 90% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58 (s, 1H), 7.36 (t, <i>J</i> = 8.2 Hz, 1H), 7.05 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (d, <i>J</i> = 7.9 Hz, 1H), 4.24 (q, <i>J</i> = 7.2 Hz, 2H), 4.16 (q, <i>J</i> = 7.1 Hz, 2H), 3.87 (s, 3H), 1.27 (t, <i>J</i> = 7.1 Hz, 3H), 1.12 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.94, 162.88, 151.25, 140.28, 135.29, 131.38 (2C), 127.75, 120.06, 114.03, 62.00, 61.73, 56.55, 13.98, 13.72. ESI-MS <i>m</i>/<i>z</i>: 324.1 (M+H<sup>+</sup>).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure B for the Synthesis of Methyl and Ethyl 1-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylates (<b>11a</b> and <b>11b</b>)</h3><div class="NLM_p">Compound <b>10a</b> or <b>10b</b> (0.5 mmol) was dissolved in acetic acid (3 mL) with or without added DMSO (0.8 mmol), followed by the addition of platinum(IV) oxide (0.075 mmol), and the mixture was stirred at room temperature under H<sub>2</sub> (22 h). The mixture was filtered and washed by MeOH, and the filtrate was concentrated and purified by Combiflash silica gel chromatography (hexanes and EtOAc) to yield products <b>11a</b> or <b>11b</b>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Methyl 1-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (<b>11a</b>)</h4><div class="NLM_p last">Treatment of <b>10a</b> as outlined in general procedure B, without the inclusion of DMSO, afforded <b>11a</b> as a white solid in 0.7% yield. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.80–7.77 (m, 3H), 7.39–7.36 (m, 1H), 4.01 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 220.0 (M+H<sup>+</sup>).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl 1-Hydroxy-8-methoxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (<b>11b</b>)</h4><div class="NLM_p last">Treatment of <b>10b</b> as outlined in general procedure B with the inclusion of DMSO afforded <b>11b</b> as a yellow oil in 82% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 7.31–7.29 (m, 1H), 7.23–7.22 (m, 1H), 7.21 (d, <i>J</i> = 1.6 Hz, 1H), 4.41 (q, <i>J</i> = 7.1 Hz, 2H), 3.96 (s, 3H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.68, 154.45, 146.70, 141.82, 127.52, 123.81, 122.68, 119.21, 118.55, 116.62, 61.81, 57.64, 14.26. ESI-MS <i>m</i>/<i>z</i>: 264.1 (M+H<sup>+</sup>).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure C for the Synthesis of <i>N</i>-(Benzyl)-1-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides (<b>12c</b> and <b>13a</b>–<b>13c</b>)</h3><div class="NLM_p">A mixture of <b>11a</b> or <b>11b</b> (0.4 mmol) with benzylamine (3 mL) was heated with stirring (60 °C, 14 h), and the resulting product mixture was purified by reverse-phase HPLC to provide <b>12c</b> or <b>13a</b>–<b>13c</b>.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>12c</b>)</h4><div class="NLM_p last">Treatment of <b>11a</b> with 2,4-difluorobenzylamine as outlined in general procedure C with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 60% B over 30 min; retention time = 28.1 min) provided <b>12c</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 10.06 (t, <i>J</i> = 6.2 Hz, 1H), 8.84 (s, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 7.82–7.76 (m, 2H), 7.49–7.38 (m, 2H), 7.26 (t, <i>J</i> = 10.0 Hz, 1H), 7.08 (t, <i>J</i> = 8.5 Hz, 1H), 4.61 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 331.1 (M+H<sup>+</sup>). HRMS calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [MH<sup>+</sup>], 331.0889; found, 331.0884.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(3-Chloro-4-fluorobenzyl)-1-hydroxy-8-methoxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>13a</b>)</h4><div class="NLM_p last">Reaction of <b>11b</b> and 3-chloro-4-fluorobenzylamine as outlined in general procedure C with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time =27.6 min) provided <b>13a</b> as a white solid in 62% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.18 (s, 1H), 10.01 (t, <i>J</i> = 6.0 Hz, 1H), 8.70 (s, 1H), 7.57 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.53–7.51 (m, 1H), 7.34 (ddd, <i>J</i> = 7.2, 6.8, 1.1 Hz, 3H), 7.26 (t, <i>J</i> = 7.9 Hz, 1H), 4.52 (d, <i>J</i> = 6.0 Hz, 2H), 3.83 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 377.0 (M+H<sup>+</sup>).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(3,4-Difluorobenzyl)-1-hydroxy-8-methoxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>13b</b>)</h4><div class="NLM_p last">Reaction of <b>11b</b> and 3,4-difluorobenzylamine as outlined in general procedure C with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time = 24.8 min) provided <b>13b</b> as a white solid in 78% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.08 (t, <i>J</i> = 6.0 Hz, 1H), 8.66 (s, 1H), 7.55 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.38–7.21 (m, 3H), 7.17–7.14 (m, 1H), 7.12–7.08 (m, 1H), 4.51 (d, <i>J</i> = 5.9 Hz, 2H), 3.80 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 361.1 (M+H<sup>+</sup>).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-8-methoxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>13c</b>)</h4><div class="NLM_p last">Reaction of <b>11b</b> and 2,4-difluorobenzylamine as outlined in general procedure C with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time = 27.0 min) provided <b>13c</b> as a white solid in 74% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.24 (s, 1H), 10.04 (t, <i>J</i> = 6.1 Hz, 1H), 8.75 (s, 1H), 7.62 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.47 (dd, <i>J</i> = 15.3, 8.7 Hz, 1H), 7.42–7.40 (m, 1H), 7.32 (t, <i>J</i> = 7.9 Hz, 1H), 7.29–7.23 (m, 1H), 7.08 (dd, <i>J</i> = 11.1, 8.6 Hz, 1H), 4.59 (d, <i>J</i> = 5.9 Hz, 2H), 3.88 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 361.1 (M+H<sup>+</sup>). HRMS calcd for C<sub>18</sub>H<sub>15</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> [MH<sup>+</sup>], 361.0994; found, 361.0990.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure D for the Synthesis of 1,8-Dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides (<b>6a</b>–<b>6c</b>)</h3><div class="NLM_p">HPLC-purified compounds <b>13a</b>–<b>13c</b> (0.1 mmol) were stirred at room temperature with boron tribromide (0.8 mmol, 2.0 M in CH<sub>2</sub>Cl<sub>2</sub>) (overnight). The reaction was quenched by the addition of MeOH, and the product mixture was purified by reverse-phase HPLC to provide <b>6a</b>–<b>6c</b>.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(3-Chloro-4-fluorobenzyl)-1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>6a</b>)</h4><div class="NLM_p last">Treatment of <b>13a</b> as outlined in general procedure D with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time =27.5 min) provided <b>6a</b> as a white solid in 36% yield.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.14 (t, <i>J</i> = 6.0 Hz, 1H), 8.63 (s, 1H), 7.42 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 7.39 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.25–7.22 (m, 3H), 7.17 (t, <i>J</i> = 7.9 Hz, 1H), 7.06 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H), 4.41 (dd, <i>J</i> = 17.7, 6.0 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 363.0 (M+H<sup>+</sup>). HRMS calcd C<sub>17</sub>H<sub>13</sub>FClN<sub>2</sub>O<sub>4</sub> [MH<sup>+</sup>], 363.0542; found, 363.0551.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(3,4-Difluorobenzyl)-1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>6b</b>)</h4><div class="NLM_p last">Treatment of <b>13b</b> as outlined in general procedure D with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time = 24.9 min) provided <b>6b</b> as a white solid in 42% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.14 (t, <i>J</i> = 6.1 Hz, 1H), 8.63 (s, 1H), 7.39 (t, <i>J</i> = 6.4 Hz, 1H), 7.29–7.23 (m, 2H), 7.16 (t, <i>J</i> = 7.9 Hz, 2H), 7.06 (dd, <i>J</i> = 7.8, 1.2 Hz, 2H), 4.42 (dd, <i>J</i> = 24.5, 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 347.1 (M+H<sup>+</sup>). HRMS calcd C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> [MH<sup>+</sup>], 347.0838; found, 347.0847.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(2,4-Difluorobenzyl)-1,8-dihydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide (<b>6c</b>)</h4><div class="NLM_p last">Treatment of <b>13c</b> as outlined in general procedure D with purification by preparative reverse-phase HPLC (linear gradient of 30% B to 65% B over 30 min; retention time = 24.6 min) provided <b>6c</b> as a white solid in 38% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.99 (t, <i>J</i> = 5.6 Hz, 1H), 8.67 (s, 1H), 7.41 (dd, <i>J</i> = 15.7, 8.0 Hz, 2H), 7.23–7.11 (m, 3H), 7.04 (dd, <i>J</i> = 19.0, 8.2 Hz, 2H), 4.54 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 347.1 (M+H<sup>+</sup>). HRMS calcd for C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> [MH<sup>+</sup>], 347.0838; found, 347.0835.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 2-(<i>N</i>-(Benzyloxy)-3-methoxy-3-oxopropanamido)nicotinate (<b>15</b>)</h4><div class="NLM_p last">A solution of commercially available methyl 2-fluoronicotinate (<b>14</b>) (1 mmol), <i>O</i>-benzylhydroxylamine (3 mmol), and <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (3 mmol) in DMSO was subjected to microwave irradiation with stirring (140 °C, 10 h). The resulting mixture was extracted (EtOAc), the organic phase was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>), the crude product was filtered, and the filtrate was concentrated. Purification by Combiflash silica gel chromatography (hexanes and EtOAc) provided intermediate methyl 2-((benzyloxy)amino)nicotinate as a yellow oil in 86% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.03 (s, 1H), 8.49 (dd, <i>J</i> = 4.8, 1.9 Hz, 1H), 8.15 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 7.50–7.47 (m, 2H), 7.41–7.34 (m, 3H), 6.79 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 5.08 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.62, 159.66, 153.68 (2C), 139.85, 136.38, 128.86, 128.44, 128.26, 114.58, 114.55, 107.03, 78.05, 52.15. ESI-MS <i>m</i>/<i>z</i>: 259.1 (M+H<sup>+</sup>). To a solution of this material (2 mmol) and triethylamine (4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added methyl 3-chloro-3-oxopropanoate (4 mmol) dropwise, and the mixture was stirred at room temperature (2 h). The crude product was filtered, the filtrate was concentrated, and the residue was purified by Combiflash silica gel chromatography (hexanes and EtOAc) to provide <b>15</b> as a yellow oil in 83% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.64 (s, 1H), 8.18 (d, <i>J</i> = 7.6 Hz, 1H), 7.39–7.38 (m, 2H), 7.35–7.32 (m, 4H), 5.03 (s, 2H), 3.88 (s, 3H), 3.72 (s, 3H), 3.61 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.09 (2C), 165.37, 151.13, 139.33, 133.89, 129.59 (3C), 128.94, 128.45 (2C), 123.83, 122.73, 78.18, 52.70, 52.32, 41.13. ESI-MS <i>m</i>/<i>z</i>: 359.1(M+H<sup>+</sup>).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 1-(Benzyloxy)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate (<b>16</b>)</h4><div class="NLM_p last">To a solution of <b>15</b> (1.7 mmol) in MeOH (30 mL) was added sodium methanolate (4.2 mmol) (25% in MeOH) at room temperature, and the resulting suspension was stirred at room temperature (overnight). Acidification to pH 4 by the addition of aqueous 2 N HCl gave a precipitate, which was collected and dried to provide <b>16</b> as a white solid in 93% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.46 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.73–7.71 (m, 2H), 7.41–7.36 (m, 3H), 7.28–7.25 (m, 1H), 5.28 (s, 2H), 4.08 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.35, 170.14, 156.40, 154.73, 149.54, 134.67, 134.08, 130.00 (2C), 128.94, 128.34 (2C), 118.70, 109.53, 98.85, 78.12, 53.29. ESI-MS <i>m</i>/<i>z</i>: 327.1 (M+H<sup>+</sup>).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure E for the Synthesis of 1,4-Dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>8a</b>–<b>c</b>) and 4-Hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>20a</b>–<b>20c</b>)</h3><div class="NLM_p">To a degassed solution of <b>16</b> (0.2 mmol) and MeOH (15 mL) with EtOAc (5 mL) was added Pd·C (10%, 0.2 mmol), and the mixture was stirred at room temperature under H<sub>2</sub> (1 h). The mixture was filtered, and the filtrate was concentrated and dissolved in DMF (1.0 mL). To this was added the appropriate halobenzylamine (2.0 mmol), and the solution was subjected to microwave irradiation with stirring (140 °C, 2 h). Purification of the reaction mixture by reverse-phase HPLC provided the desired final products <b>8a</b>–<b>c</b> as well as the over-reduced products <b>20a</b>–<b>20c</b>.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(3-Chloro-4-fluorobenzyl)-1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>8a</b>) and <i>N</i>-(3-Chloro-4-fluorobenzyl)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>20a</b>)</h4><div class="NLM_p last">Treatment of <b>16</b> as outlined in general procedure E using 3-chloro-4-fluorobenzylamine with purification by preparative reverse-phase HPLC (linear gradient of 20% B to 80% B over 30 min) provided a 43% yield of <b>8a</b> and <b>20a</b> as white solids in a 2:1 ratio. For <b>8a</b>: retention time = 26.4 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (bs, 1H), 10.52 (bs, 1H), 8.84 (dd, <i>J</i> = 4.6, 1.7 Hz, 1H), 8.47 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.60 (d, <i>J</i> = 7.6 Hz, 1H), 7.48–7.42 (m, 1H), 7.42 (d, <i>J</i> = 7.7 Hz, 2H), 4.61 (d, <i>J</i> = 6.2 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 364.0 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>ClFN<sub>3</sub>O<sub>4</sub> [MH<sup>+</sup>], 364.0495; found, 364.0490. For <b>20a</b>: retention time = 30.7 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.31 (s, 1H), 10.59 (t, <i>J</i> = 5.8 Hz, 1H), 8.70 (d, <i>J</i> = 4.6 Hz, 1H), 8.36 (d, <i>J</i> = 7.6 Hz, 1H), 7.60 (d, <i>J</i> = 7.0 Hz, 1H), 7.41 (dd, <i>J</i> = 9.8, 7.0 Hz, 2H), 7.36 (dd, <i>J</i> = 7.9, 4.9 Hz, 1H), 4.59 (d, <i>J</i> = 6.3 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 348.0 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>ClFN<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 348.0546; found, 348.0541.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(3,4-Difluorobenzyl)-1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>8b</b>) and <i>N</i>-(3,4-Difluorobenzyl)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>20b</b>)</h4><div class="NLM_p last">Treatment of <b>16</b> as outlined in general procedure E using 3,4-difluorobenzylamine with purification by preparative reverse-phase HPLC (linear gradient of 20% B to 80% B over 30 min) provided a 54% yield of <b>8b</b> and <b>20b</b> as white solids in a 1:1 ratio. For <b>8b</b>: retention time = 22.2 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 10.52 (s, 1H), 8.84 (dd, <i>J</i> = 4.6, 1.8 Hz, 1H), 8.47 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.51–7.37 (m, 3H), 7.24 (s, 1H), 4.60 (d, <i>J</i> = 6.2 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 348.0 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [MH<sup>+</sup>], 348.0790; found, 348.0784. For <b>20b</b>: retention time = 27.4 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.33 (s, 1H), 10.59 (s, 1H), 8.70 (d, <i>J</i> = 3.1 Hz, 1H), 8.37 (d, <i>J</i> = 7.8 Hz, 1H), 7.43 (dd, <i>J</i> = 14.0, 5.4 Hz, 2H), 7.42–7.34 (m, 1H), 7.23 (bs, 1H), 4.59 (d, <i>J</i> = 6.1 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 332.1 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 332.0841; found, 332.0835.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(2,4-Difluorobenzyl)-1,4-dihydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>8c</b>) and <i>N</i>-(2,4-Difluorobenzyl)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>20c</b>)</h4><div class="NLM_p last">Treatment of <b>16</b> as outlined in general procedure E using 2,4-difluorobenzylamine with purification by preparative reverse-phase HPLC (linear gradient of 20% B to 80% B over 30 min) provided a 45% yield of <b>8c</b> and <b>20c</b> as white solids in a 1:1 ratio. For <b>8c</b>: retention time = 24.7 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 10.42 (s, 1H), 8.77 (d, <i>J</i> = 4.6 Hz, 1H), 8.40 (d, <i>J</i> = 7.9 Hz, 1H), 7.49–7.41 (m, 1H), 7.41–7.34 (m, 1H), 7.21 (t, <i>J</i> = 10.1 Hz, 1H), 7.03 (t, <i>J</i> = 8.2 Hz, 1H), 4.57 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 348.0 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> [MH<sup>+</sup>], 348.0790; found, 348.0787. For <b>20c</b>: retention time = 29.0 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.32 (s, 1H), 10.57 (s, 1H), 8.70 (s, 1H), 8.36 (d, <i>J</i> = 7.4 Hz, 1H), 7.48 (d, <i>J</i> = 7.5 Hz, 1H), 7.36 (s, 1H), 7.28 (t, <i>J</i> = 9.6 Hz, 1H), 7.10 (s, 1H), 4.62 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 332.1 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 332.0841; found, 332.0839.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 1-(Benzyloxy)-2-oxo-4-(((trifluoromethyl)sulfonyl)oxy)-1,2-dihydro-1,8-naphthyridine-3-carboxylate (<b>17</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (268 mg, 0.82 mmol) and triethylamine (0.27 mL, 1.97 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added trifluoromethanesulfonic anhydride (0.17 mL, 0.98 mmol) at 0 °C, and the solution was stirred at 0 °C (0.5 h). The mixture was concentrated and purified by Combiflash silica gel chromatography to provide <b>17</b> as a white solid (301 mg, 80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.86 (dd, <i>J</i> = 4.7, 1.7 Hz, 1H), 8.21 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.70–7.67 (m, 2H), 7.43–7.38 (m, 4H), 5.34 (s, 2H), 4.01 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.87, 155.20, 154.02, 153.98, 148.70, 148.09, 133.32, 133.23, 130.12, 129.33, 128.48, 120.84, 119.91, 119.86, 116.67, 109.73, 78.72, 53.50. ESI-MS <i>m</i>/<i>z</i>: 459.0 (M+H<sup>+</sup>).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 1-(Benzyloxy)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate (<b>18</b>)</h4><div class="NLM_p last">To a mixture of <b>17</b> (34 mg, 0.074 mmol) and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (5 mg, 7.37 μmol) in DMF (1 mL), triethylamine (0.030 mL, 0.22 mmol) and triisopropylsilane (17 mg, 0.15 mmol) were added. The mixture was heated to 85 °C (24 h). The resulting crude mixture was purified by Combiflash silica gel chromatography (hexanes and EtOAc) to provide <b>18</b> as a white solid (12 mg, 52% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.41 (s, 1H), 7.99 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.69 (dd, <i>J</i> = 7.6, 1.8 Hz, 2H), 7.38–7.30 (m, 3H), 7.26–7.23 (m, 1H), 5.29 (s, 2H), 3.96 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.47, 153.41, 141.78, 138.27, 133.86, 132.08, 131.99, 130.10 (2C), 129.05, 128.50, 128.37 (2C), 119.32, 113.30, 78.21, 52.90. ESI-MS <i>m</i>/<i>z</i>: 311.1 (M+H<sup>+</sup>).</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure F for the Synthesis of 1-(Benzyloxy)-<i>N</i>-(halobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>19a</b>–<b>19c</b>)</h3><div class="NLM_p">A solution of <b>18</b> (0.6 mmol) and halobenzylamine (1 mL) was heated with stirring (60 °C, 14 h). The mixture was then extracted (CHCl<sub>3</sub>) and washed sequentially with aqueous 1 N HCl and brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The organic phase was filtered and concentrated, and the crude residue was purified by Combiflash silica gel chromatograpy (hexanes and EtOAc) to provide amides <b>19(a</b>–<b>c)</b>.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(Benzyloxy)-<i>N</i>-(3-chloro-4-fluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>19a</b>)</h4><div class="NLM_p last">Treatment of <b>18</b> with 3-chloro-4-difluorobenzylamine as outlined in general procedure F provided <b>19a</b> as a white solid in 31% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.90 (t, <i>J</i> = 5.7 Hz, 1H), 8.81 (s, 1H), 8.75 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.06 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.61–7.60 (m, 1H), 7.59 (d, <i>J</i> = 1.7 Hz, 1H), 7.36–7.32 (m, 2H), 7.31–7.27 (m, 3H), 7.19–7.15 (m, 1H), 7.03 (t, <i>J</i> = 8.7 Hz, 1H), 5.27 (s, 2H), 4.56 (d, <i>J</i> = 6.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.45, 159.38, 157.35 (d, <i>J</i> = 248.3 Hz), 153.33, 148.97, 141.41, 138.72, 135.31 (d, <i>J</i> = 3.9 Hz), 133.56, 129.94 (2C), 129.87, 129.24, 128.49 (2C), 128.38 (d, <i>J</i> = 15.3 Hz), 127.43 (d, <i>J</i> = 7.3 Hz), 123.36, 120.00, 116.61 (d, <i>J</i> = 21.2 Hz), 114.12, 78.57, 42.58. ESI-MS <i>m</i>/<i>z</i>: 438.1 (M+H<sup>+</sup>).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(Benzyloxy)-<i>N</i>-(3,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>19b</b>)</h4><div class="NLM_p last">Treatment of <b>18</b> with 3,4-difluorobenzylamine as outlined in general procedure F provided <b>19b</b> as a white solid in 51% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.95 (t, <i>J</i> = 5.8 Hz, 1H), 8.85 (s, 1H), 8.78 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.09 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.65–7.64 (m, 1H), 7.62 (d, <i>J</i> = 1.7 Hz, 1H), 7.37–7.30 (m, 4H), 7.20–7.13 (m, 1H), 7.09–7.03 (m, 1H), 6.98–6.94 (m, 1H), 5.29 (s, 2H), 4.59 (d, <i>J</i> = 6.0 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 422.1 (M+H<sup>+</sup>).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>19c</b>)</h4><div class="NLM_p last">Treatment of <b>18</b> with 2,4-difluorobenzylamine as outlined in general procedure F provided <b>19c</b> as a white solid in 22% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.92 (d, <i>J</i> = 5.4 Hz, 1H), 8.87 (s, 1H), 8.82 (ddd, <i>J</i> = 4.7, 1.7, 0.6 Hz, 1H), 8.13 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.69 (d, <i>J</i> = 2.4 Hz, 1H), 7.68 (dd, <i>J</i> = 3.3, 1.3 Hz, 1H), 7.42–7.34 (m, 5H), 6.88–6.76 (m, 2H), 5.34 (s, 2H), 4.69 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 422.1 (M+H<sup>+</sup>).</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure G for the Synthesis of 1-(Benzyloxy)-<i>N</i>-(halobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>7</b>(<b>a</b>–<b>c</b>)</h3><div class="NLM_p">To a solution of amide (<b>19a</b>–<b>19c</b>) (0.2 mmol) in a solution of MeOH (10 mL) and EtOAc (3 mL) was added Pd·C (10%, 20 mg), and the mixture was degassed and stirred at room temperature under H<sub>2</sub> (1 h). The mixture was then filtered through a small pad of silica gel, the filtrate was concentrated, and the residue was purified by preparative reverse-phase HPLC to provide the target amides <b>7a</b>–<b>c</b>.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-Chloro-4-fluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>7a</b>)</h4><div class="NLM_p last">Treatment of <b>19a</b> as outlined in general procedure G and purification by preparative reverse-phase HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 22.5 min) provided <b>7a</b> as a white solid in 41% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (bs, 1H), 9.96 (t, <i>J</i> = 5.9 Hz, 1H), 8.85 (s, 1H), 8.82 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.51 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 4.7 Hz, 1H), 7.40–7.37 (m, 2H), 4.58 (d, <i>J</i> = 6.0 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 348.0 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>ClFN<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 348.0546; found, 348.0542.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3,4-Difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>7b</b>)</h4><div class="NLM_p last">Treatment of <b>19b</b> as outlined in general procedure G and purification by preparative reverse-phase HPLC (linear gradient of 20% B to 50% B over 30 min; retention time = 26.1 min) provided <b>7b</b> as a white solid in 22% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (bs, 1H), 9.96 (t, <i>J</i> = 6.0 Hz, 1H), 8.85 (s, 1H), 8.82 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.52 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.47 (dd, <i>J</i> = 7.8, 4.7 Hz, 1H), 7.45–7.37 (m, 2H), 7.23–7.22 (m, 1H), 4.58 (d, <i>J</i> = 6.1 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 332.1 (M+H<sup>+</sup>). HRMS calcd C<sub>18</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 332.0841; found, 332.0828.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>7c</b>)</h4><div class="NLM_p last">Treatment of <b>19c</b> as outlined in general procedure G and purification by preparative reverse-phase HPLC (linear gradient of 20% B to 80% B over 30 min; retention time = 19.2 min) provided <b>7c</b> as a white solid in 52% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (t, <i>J</i> = 5.9 Hz, 1H), 8.78 (s, 1H), 8.75 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.45 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.46–7.34 (m, 2H), 7.19 (ddd, <i>J</i> = 10.6, 9.4, 2.6 Hz, 1H), 7.03–6.98 (m, 1H), 4.54 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 332.1 (M+H<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>12</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [MH<sup>+</sup>], 332.0841; found, 332.0834.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Integrase Assays</h3><div class="NLM_p last">IN reactions were performed as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Briefly, reactions were carried out by adding compounds or an equivalent volume of 100% DMSO (used as solvent for the compounds) to a mixture of 20 nM [γ-<sup>32</sup>P]-labeled DNA and 400 nM IN in a buffer containing 50 mM morpholinepropanesulfonic acid (pH 7.2), 7.5 mM MgCl<sub>2</sub>, and 14 mM 2-mercaptoethanol. [γ-<sup>32</sup>P]-labeled full length oligonucleotide 21T (GTGTGGAAAATCTCTAGCAGT) or precleaved oligonucleotide 19T (GTGTGGAAAATCTCTAGCA), both annealed to the complementary oligonucleotide 21B (ACTGCTAGAGATTTTCCACAC), were used to measure both 3′-processing and strand transfer, respectively.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Reactions were performed at 37 °C for 2 h and quenched by the addition of an equal volume of loading buffer (formamide containing 1% sodium dodecyl sulfate, 0.25% bromophenol blue, and xylene cyanol). Reaction products were separated in 16% polyacrylamide-denaturing sequencing gels. Dried gels were visualized using Typhoon 8600 (GE Healthcare, Piscataway, NJ). Densitometric analyses were performed using ImageQuant 5.1 software from GE Healthcare. The data analyses (linear regression, 50% inhibitory concentration [IC<sub>50</sub>] determination, and standard deviation [SD]) were performed from at least 3 independent determinations using Prism 5.0c software from GraphPad.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Cellular Cytotoxicity Assays</h3><div class="NLM_p last">The human osteosarcoma cell line, HOS, was obtained from Dr. Richard Schwartz (Michigan State University, East Lansing, MI) and grown in Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA) supplemented with 5% (v/v) fetal bovine serum, 5% newborn calf serum, and penicillin (50 units/mL) plus streptomycin (50 μg/mL; Quality Biological, Gaithersburg, MD). On the day prior to the screen, HOS cells were seeded in a 96-well luminescence cell culture plate at a density of 4000 cells in 100 μL per well. On the day of the screen, cells were treated with compounds in the appropriate concentration range chosen and incubated at 37 °C for 48 h. Cytotoxicity was measured by monitoring ATP levels via a luciferase reporter assay. Cells were lysed in 50 μL of cell lysis buffer (PerkinElmer, Waltham, MA) and shaken at 700 rpm at room temperature for 5 min. After the addition of 50 μL of ATPlite buffer (PerkinElmer) directly onto the lysed cells and shaking at 700 rpm at room temperature (5 min), ATP levels were monitored by measuring luciferase activity using a microplate reader. Activity was normalized to cytotoxicity in the absence of target compounds. KaleidaGraph (Synergy Software, Reading, PA) was used to perform regression analysis on the data. CC<sub>50</sub> values were determined from the fit model.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Single-Round HIV-1 Infectivity Assays</h3><div class="NLM_p last">Human embryonic kidney cell line 293T was transfected with the pNLNgoMIVR-ΔLUC vector, which was made from pNLNgoMIVR-Δ<i>E</i>nv·HSA by removing the HSA reporter gene and replacing it with a luciferase reporter gene between the NotI and XhoI restriction sites.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> VSV-g-pseudotyped HIV was produced by transfections of 293T cells as described previously.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> On the day prior to transfection, 293T cells were plated on 100-mm-diameter dishes at a density of 1.5 × 10<sup>6</sup> cells per plate. 293T cells were transfected with 16 μg of pNLNgoMIVR-ΔLUC and 4 μg of pHCMV-g (obtained from Dr. Jane Burns, University of California, San Diego) using the calcium phosphate method. At approximately 6 h after the calcium phosphate precipitate was added, the 293T cells were washed twice with phosphate-buffered saline (PBS) and incubated with fresh media (48 h). The virus-containing supernatants were then harvested, clarified by low-speed centrifugation, filtered, and diluted for preparation in infection assays. On the day prior to the screen, HOS cells were seeded in a 96-well luminescence cell culture plate at a density of 4000 cells in 100 μL per well. On the day of the screen, cells were treated with the compounds from a concentration range of 10 μM to 0.0005 μM using 11 serial dilutions and then incubated at 37 °C (3 h). After this incubation, 100 μL of virus-stock diluted to achieve a maximum luciferase signal between 0.2 and 1.5 RLUs was added to each well, and the plates were incubated at 37 °C (48 h). Infectivity was measured by using the Steady-lite plus luminescence reporter gene assay system (PerkinElmer, Waltham, MA). Luciferase activity was measured by adding 100 μL of Steady-lite plus buffer (PerkinElmer) to the cells, incubating at room temperature (20 min), and measuring luminescence using a microplate reader. Activity was normalized to infectivity in the absence of target compounds. KaleidaGraph (Synergy Software, Reading, PA) was used to perform regression analysis on the data. EC<sub>50</sub> values were determined from the fit model.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Vector Constructs</h3><div class="NLM_p last">pNLNgoMIVR-Δ<i>E</i>nv·LUC has been described previously.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The IN coding region was removed from pNLNgoMIVR-Δ<i>E</i>nv·LUC (between <i>Kpn</i>I and <i>Sal</i>I sites) and inserted between the <i>Kpn</i>I and <i>Sal</i>I sites of pBluescript II KS+. Using that construct as the wild-type template, we prepared the following IN-resistant mutants via the QuikChange II XL (Stratagene, La Jolla, CA) site-directed mutagenesis protocol: G118R, Y143R, Q148H, Q148K, N155H, G140S + Q148H, G140A + Q148K, and E138K + Q148K. The following sense with cognate antisense (not shown) oligonucleotides (Integrated DNA Technologies, Coralville, IA) was used in the mutagenesis: G118R, 5′-GTACATACAGACAATCGCAGCAATTTCACCAGTAC-3′; E138K, 5′-GGCGGGGATCAAGCAGAAATTTGGCATTCCCTA-3′; G140A, 5′-GGGGATCAAGCAGGAATTTGCCATTCCCTACAATC-3′; G140S, 5′-GGGGATCAAGCAGGAATTTAGCATTCCCTACAATC-3′; Y143R, 5′-GCAGGAATTTGGCATTCCCCGCAATCCCCAAAGTCAAGGA-3′; Q148H, 5′-CATTCCCTACAATCCCCAAAGTCATGGAGTAATAGAATCTA-3′; Q148K, 5′-CATTCCCTACAATCCCCAAAGTAAAGGAGTAATAGAATCTATGAA-3′; and N155H, 5′-CCAAAGTCAAGGAGTAATAGAATCTATGCATAAAGAATTAAAGAAAATTATAGGACA-3′. The double mutant G140S + Q148H was constructed by using the previously generated Q148H mutant and the appropriate oligonucleotide to introduce the second mutation, G140S. The double mutant G140A + Q148K was made by using the Q148K mutant and the appropriate oligonucleotide to introduce the second mutation, G140A. The double mutant E138K + Q148K was made by using the Q148K mutant and the appropriate oligonucleotide to introduce the second mutation, E138K. The DNA sequence of each construct was verified independently by DNA sequencing. The mutant IN coding sequences from pBluescript II KS+ were then subcloned into pNLNgoMIVR-Δ<i>E</i>nv·LUC (between the <i>Kpn</i>I and <i>Sal</i>I sites) to produce the full-length mutant HIV-1 IN constructs. These DNA sequences were additionally checked independently by DNA sequencing.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm401902n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrence R. Burke</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">HIV
Drug Resistance Program, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland 20892, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e68493948d839283a68e838a8f9ec8888f8ec8818990"><span class="__cf_email__" data-cfemail="a1c3d4d3cac4d5c4e1c9c4cdc8d98fcfc8c98fc6ced7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue Zhi Zhao</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">HIV
Drug Resistance Program, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven J. Smith</span> - <span class="hlFld-Affiliation affiliation">HIV
Drug Resistance Program, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathieu Métifiot</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry C. Johnson</span> - <span class="hlFld-Affiliation affiliation">HIV
Drug Resistance Program, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Marchand</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Pommier</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen H. Hughes</span> - <span class="hlFld-Affiliation affiliation">HIV
Drug Resistance Program, National Cancer
Institute-Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.<br /></br>The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1264e3780-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by the Intramural Research Program of the NIH, Center for Cancer Research, Frederick National Laboratory for Cancer Research and the National Cancer Institute, National Institutes of Health and the Joint Science and Technology Office of the Department of Defense, and by funds from the Intramural AIDS Targeted Antiviral Program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> Abbreviations Used</h2><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immune deficiency syndrome</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term">RAL</td><td class="NLM_def"><p class="first last">Raltegravir</p></td></tr><tr><td class="NLM_term">EVG</td><td class="NLM_def"><p class="first last">Elvitegravir</p></td></tr><tr><td class="NLM_term">DTG</td><td class="NLM_def"><p class="first last">Dolutegravir</p></td></tr><tr><td class="NLM_term">3′-P</td><td class="NLM_def"><p class="first last">3′-processing</p></td></tr><tr><td class="NLM_term">ST</td><td class="NLM_def"><p class="first last">strand transfer</p></td></tr><tr><td class="NLM_term">INSTIs</td><td class="NLM_def"><p class="first last">integrase strand transfer inhibitors</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: 20-Year landmark and challenges</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=75-105&author=M.+Metifiotauthor=C.+Marchandauthor=Y.+Pommier&title=HIV+integrase+inhibitors%3A+20-Year+landmark+and+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%252020-Year%2520landmark%2520and%2520challenges%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2013%26volume%3D67%26spage%3D75%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">Inhibiting the HIV integration process: past, present, and the future</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm400674a</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400674a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Di+Santo&title=Inhibiting+the+HIV+integration+process%3A+past%2C+present%2C+and+the+future&doi=10.1021%2Fjm400674a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm400674a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400674a%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DInhibiting%2520the%2520HIV%2520integration%2520process%253A%2520past%252C%2520present%252C%2520and%2520the%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400674a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. J.</span><span> </span><span class="NLM_article-title">Raltegravir: In treatment-naive patients with HIV-1 infection</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=631-642&author=J.+D.+Croxtallauthor=L.+J.+Scott&title=Raltegravir%3A+In+treatment-naive+patients+with+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DScott%26aufirst%3DL.%2BJ.%26atitle%3DRaltegravir%253A%2520In%2520treatment-naive%2520patients%2520with%2520HIV-1%2520infection%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D631%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wills, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V.</span><span> </span><span class="NLM_article-title">Elvitegravir: A once-daily inhibitor of HIV-1 integrase</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=395-401&author=T.+Willsauthor=V.+Vega&title=Elvitegravir%3A+A+once-daily+inhibitor+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills%26aufirst%3DT.%26aulast%3DVega%26aufirst%3DV.%26atitle%3DElvitegravir%253A%2520A%2520once-daily%2520inhibitor%2520of%2520HIV-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV-1 IN inhibitors: 2010 Update and perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.2174%2F156802609789630910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=19747122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1016-1037&author=C.+Marchandauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Pommier&title=HIV-1+IN+inhibitors%3A+2010+Update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 IN inhibitors: 2010 update and perspectives</span></div><div class="casAuthors">Marchand, Christophe; Maddali, Kasthuraiah; Metifiot, Mathieu; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1016-1037</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is the newest validated target against AIDS and retroviral infections.  The remarkable activity of raltegravir (Isentress) led to its rapid approval by the FDA in 2007 as the first IN inhibitor.  Several other IN strand transfer inhibitors (STIs) are in development with the primary goal to overcome resistance due to the rapid occurrence of IN mutations in raltegravir-treated patients.  Thus, many scientists and drug companies are actively pursuing clin. useful IN inhibitors.  The objective of this review is to provide an update on the IN inhibitors reported in the last two years, including second generation STI, recently developed hydroxylated aroms., natural products, peptide, antibody and oligonucleotide inhibitors.  Addnl., the targeting of IN cofactors such as LEDGF and Vpr will be discussed as novel strategies for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpn7mNYPX9bVg90H21EOLACvtfcHk0lhrJoJj7e2Qzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN&md5=f1820ab6d7faa583030f4fd5c6872acb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802609789630910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630910%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV-1%2520IN%2520inhibitors%253A%25202010%2520Update%2520and%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1016%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Resistance to integrase inhibitors</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.3390%2Fv2071347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=20706558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1anu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1347-1366&author=M.+Metifiotauthor=C.+Marchandauthor=K.+Maddaliauthor=Y.+Pommier&title=Resistance+to+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to integrase inhibitors</span></div><div class="casAuthors">Metifiot, Mathieu; Marchand, Christophe; Maddali, Kasthuraiah; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1347-1366</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is a clin. validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clin. activity.  The next most advanced IN inhibitor is elvitegravir.  However, mutant viruses lead to treatment failure and mutations within the IN coding sequence appear to confer cross-resistance.  The characterization of those mutations is crit. for the development of second generation IN inhibitors to overcome resistance.  This review focuses on IN resistance based on structural and biochem. data, and on the role of the IN flexible loop i.e., between residues G140-G149 in drug action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzaFeDwbAmz7Vg90H21EOLACvtfcHk0lhrJoJj7e2Qzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1anu70%253D&md5=f808e1a78587d971351107f9a4e9befa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3390%2Fv2071347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2071347%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DResistance%2520to%2520integrase%2520inhibitors%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26spage%3D1347%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span> </span><span class="NLM_article-title">Structural insights into the retroviral DNA integration apparatus</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1016%2Fj.sbi.2010.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=21277766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=249-256&author=P.+Cherepanovauthor=G.+N.+Maertensauthor=S.+Hare&title=Structural+insights+into+the+retroviral+DNA+integration+apparatus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the retroviral DNA integration apparatus</span></div><div class="casAuthors">Cherepanov, Peter; Maertens, Goedele N.; Hare, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Retroviral replication depends on successful integration of the viral genetic material into a host cell chromosome.  Virally encoded integrase, an enzyme from the DDE(D) nucleotidyltransferase superfamily, is responsible for the key DNA cutting and joining steps assocd. with this process.  Insights into the structural and mechanistic aspects of integration are directly relevant for the development of antiretroviral drugs.  Recent breakthroughs have led to biochem. and structural characterization of the principal integration intermediates revealing the tetramer of integrase that catalyzes insertion of both 3' viral DNA ends into a sharply bent target DNA.  This review discusses the mechanism of retroviral DNA integration and the mode of action of HIV-1 integrase strand transfer inhibitors in light of the recent visualization of the prototype foamy virus intasome, target DNA capture and strand transfer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt41KftkBkbVg90H21EOLACvtfcHk0liDOlC2BTFjsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D&md5=b60c38e193175b2576a27b8a7a40ad80</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DMaertens%26aufirst%3DG.%2BN.%26aulast%3DHare%26aufirst%3DS.%26atitle%3DStructural%2520insights%2520into%2520the%2520retroviral%2520DNA%2520integration%2520apparatus%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Perryman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">A dynamic model of HIV integrase inhibition and drug resistance</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=600-615&author=A.+L.+Perrymanauthor=S.+Forliauthor=G.+M.+Morrisauthor=C.+Burtauthor=Y.+Chengauthor=M.+J.+Palmerauthor=K.+Whitbyauthor=J.+A.+McCammonauthor=C.+Phillipsauthor=A.+J.+Olson&title=A+dynamic+model+of+HIV+integrase+inhibition+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerryman%26aufirst%3DA.%2BL.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DA%2520dynamic%2520model%2520of%2520HIV%2520integrase%2520inhibition%2520and%2520drug%2520resistance%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D397%26spage%3D600%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Geretti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armenia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccherini-Silberstein, F.</span><span> </span><span class="NLM_article-title">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1097%2FQCO.0b013e32835a1de7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=23086187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=677-686&author=A.+M.+Gerettiauthor=D.+Armeniaauthor=F.+Ceccherini-Silberstein&title=Emerging+patterns+and+implications+of+HIV-1+integrase+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span></div><div class="casAuthors">Geretti, Anna Maria; Armenia, Daniele; Ceccherini-Silberstein, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent data on the pathways of resistance that impact the clin. activity of first-generation and second-generation integrase inhibitors.  Recent findings: Raltegravir (RAL) and elvitegravir (EVG) are highly efficacious in first-line antiretroviral therapy, with small nos. of virol. failures obsd. in clin. trials.  Durable activity in treatment-experienced patients requires a fully supportive background regimen.  RAL and EVG show a low-to-moderate genetic barrier to resistance and extensive cross-resistance, which preclude their sequential use.  Resistance to dolutegravir (DTG) is not selected as readily in vitro and has not emerged in studies of treatment-naive patients to date.  Both in vitro and in vivo, DTG retains activity against several RAL and EVG resistant strains, but susceptibility is variably impaired by multiple mutations within the G148 pathway, which are common after RAL or EVG failure.  Cross-resistance can be partially overcome by doubling DTG dosing to twice daily, but durability of responses remains dependent on a supportive background regimen.  There is variability in the integrase gene of circulating HIV strains, which does not appear to reduce drug activity, although it may influence the emergence and evolution of integrase resistance.  Transmission of integrase resistance remains rare but surveillance is required.  Summary: Integrase inhibitors provide a potent option for the treatment of HIV infection.  Drug resistance remains a challenge, which may be partially overcome by the introduction of second-generation compds.  Prompt management of RAL and EVG failure is required to prevent the accumulation of multiple resistance mutations that reduce DTG susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJNLh3j8EBULVg90H21EOLACvtfcHk0liDOlC2BTFjsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE&md5=ad104b6dff368c146f9cef84a553506f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32835a1de7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32835a1de7%26sid%3Dliteratum%253Aachs%26aulast%3DGeretti%26aufirst%3DA.%2BM.%26aulast%3DArmenia%26aufirst%3DD.%26aulast%3DCeccherini-Silberstein%26aufirst%3DF.%26atitle%3DEmerging%2520patterns%2520and%2520implications%2520of%2520HIV-1%2520integrase%2520inhibitor%2520resistance%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D677%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span> </span><span class="NLM_article-title">Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=491-501&author=O.+Delelisauthor=S.+Thierryauthor=F.+Subraauthor=F.+Simonauthor=I.+Maletauthor=C.+Allouiauthor=S.+Sayonauthor=V.+Calvezauthor=E.+Deprezauthor=A.-G.+Marcelinauthor=L.+Tchertanovauthor=J.-F.+Mouscadet&title=Impact+of+Y143+HIV-1+integrase+mutations+on+resistance+to+raltegravir+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DThierry%26aufirst%3DS.%26aulast%3DSubra%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DAlloui%26aufirst%3DC.%26aulast%3DSayon%26aufirst%3DS.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26atitle%3DImpact%2520of%2520Y143%2520HIV-1%2520integrase%2520mutations%2520on%2520resistance%2520to%2520raltegravir%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D54%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Quashie, P. K.; Sloan, R. D.; Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Novel therapeutic strategies targeting HIV integrase</span>.  <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">34</span>), DOI: <span class="refDoi"> DOI: 10.1186/1741-7015-10-34</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1186%2F1741-7015-10-34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22498430" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&issue=34&author=P.+K.+Quashie&author=R.+D.+Sloan&author=M.+A.+Wainberg&title=Novel+therapeutic+strategies+targeting+HIV+integrase&doi=10.1186%2F1741-7015-10-34"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-34%26sid%3Dliteratum%253Aachs%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26atitle%3DNovel%2520therapeutic%2520strategies%2520targeting%2520HIV%2520integrase%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26issue%3D34%26doi%3D10.1186%2F1741-7015-10-34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span> </span><span class="NLM_article-title">Dolutegravir for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=523-530&author=C.+Katlamaauthor=R.+Murphy&title=Dolutegravir+for+the+treatment+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DDolutegravir%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D523%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ballantyne, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Dolutegravir: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1627-1637&author=A.+D.+Ballantyneauthor=C.+M.+Perry&title=Dolutegravir%3A+first+global+approval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DA.%2BD.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DDolutegravir%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D1627%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Vandeckerckhove, L.</span><span> </span><span class="NLM_article-title">GSK-1349572, a novel integrase inhibitor for the treatment of HIV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=203-212&author=L.+Vandeckerckhove&title=GSK-1349572%2C+a+novel+integrase+inhibitor+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVandeckerckhove%26aufirst%3DL.%26atitle%3DGSK-1349572%252C%2520a%2520novel%2520integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8735</span><span class="NLM_x">–</span> <span class="NLM_lpage">8744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8735%26epage%3D8744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikamiyama-Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles</span></div><div class="casAuthors">Kawasuji, Takashi; Johns, Brian A.; Yoshida, Hiroshi; Weatherhead, Jason G.; Akiyama, Toshiyuki; Taishi, Teruhiko; Taoda, Yoshiyuki; Mikamiyama-Iwata, Minako; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work is a continuation of our initial discovery of a potent monocyclic carbamoyl pyridone human immunodeficiency virus type-1 (HIV-1) integrase inhibitor that displayed favorable antiviral and pharmacokinetic properties.  We report herein a series of bicyclic carbamoylpyridone (I; satd. and unsatd. bridge; R = e.g., alkoxyethyl) analogs to address conformational issues from our initial SAR studies.  This modification of the core unit succeeded to deliver low nanomolar potency in std. antiviral assays.  An addnl. hydroxyl substituent on the bicyclic scaffold provides remarkable improvement of antiviral efficacies against clin. relevant resistant viruses.  These findings led to addnl. cyclic tethering of the naked hydroxyl group resulting in tricyclic carbamoyl pyridone inhibitors (II; Y = O, N; n = 0-2; R' = e.g., alkyl, Ac, methanesulfonyl) to address remaining issues and deliver potential clin. candidates.  The tricyclic carbamoyl pyridone derivs. described herein served as the immediate leads in mols. to the next generation integrase inhibitor dolutegravir which is currently in late stage clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLpPj5UB1TbVg90H21EOLACvtfcHk0li-obq2VHLofw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D&md5=4bfe919f8fdbbc84e346e3f01e084b70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1124%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Activities, crystal structures and molecular dynamics of dihydro-1<i>H</i>-isoindole derivatives, inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300471n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=209-217&author=M.+Metifiotauthor=K.+Maddaliauthor=B.+C.+Johnsonauthor=S.+Hareauthor=S.+J.+Smithauthor=X.+Z.+Zhaoauthor=C.+Marchandauthor=T.+R.+Burkeauthor=S.+H.+Hughesauthor=P.+Cherepanovauthor=Y.+Pommier&title=Activities%2C+crystal+structures+and+molecular+dynamics+of+dihydro-1H-isoindole+derivatives%2C+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb300471n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300471n%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BC.%26aulast%3DHare%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DActivities%252C%2520crystal%2520structures%2520and%2520molecular%2520dynamics%2520of%2520dihydro-1H-isoindole%2520derivatives%252C%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sangeetha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amutha, R.</span><span> </span><span class="NLM_article-title">Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors</span> <span class="citation_source-journal">SAR QSAR Environ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=753-771&author=B.+Sangeethaauthor=R.+Muthukumaranauthor=R.+Amutha&title=Pharmacophore+modelling+and+electronic+feature+analysis+of+hydroxamic+acid+derivatives%2C+the+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangeetha%26aufirst%3DB.%26aulast%3DMuthukumaran%26aufirst%3DR.%26aulast%3DAmutha%26aufirst%3DR.%26atitle%3DPharmacophore%2520modelling%2520and%2520electronic%2520feature%2520analysis%2520of%2520hydroxamic%2520acid%2520derivatives%252C%2520the%2520HIV%2520integrase%2520inhibitors%26jtitle%3DSAR%2520QSAR%2520Environ.%2520Res.%26date%3D2013%26volume%3D24%26spage%3D753%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">R, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7211</span><span class="NLM_x">–</span> <span class="NLM_lpage">7219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=D.+K.+Rauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+hydroxamic+acids+are+potent+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DR%26aufirst%3DD.%2BK.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520hydroxamic%2520acids%2520are%2520potent%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7211%26epage%3D7219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham Yuk, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2292</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1014378" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2282-2292&author=J.+Tangauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Sham+Yukauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=3-Hydroxypyrimidine-2%2C4-diones+as+an+inhibitor+scaffold+of+HIV+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm1014378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014378%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSham%2BYuk%26aufirst%3DY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D3-Hydroxypyrimidine-2%252C4-diones%2520as%2520an%2520inhibitor%2520scaffold%2520of%2520HIV%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2282%26epage%3D2292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahive, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel <i>N</i>-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200208d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3393-3417&author=T.+W.+Johnsonauthor=S.+P.+Tanisauthor=S.+L.+Butlerauthor=D.+Dalvieauthor=D.+M.+DeLisleauthor=K.+R.+Dressauthor=E.+J.+Flahiveauthor=Q.+Huauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=G.+A.+McClellanauthor=Q.+Pengauthor=M.+B.+Pleweauthor=P.+F.+Richardsonauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=X.+Yuauthor=J.+Zhangauthor=H.+Zhu&title=Design+and+synthesis+of+novel+N-hydroxy-dihydronaphthyridinones+as+potent+and+orally+bioavailable+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200208d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200208d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeLisle%26aufirst%3DD.%2BM.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DFlahive%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcClellan%26aufirst%3DG.%2BA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520N-hydroxy-dihydronaphthyridinones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3393%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Desimmie, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeulemeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taltynov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billamboz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelkov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotelle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span> </span><span class="NLM_article-title">2-Hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1194</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb4000426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1187-1194&author=B.+A.+Desimmieauthor=J.+Demeulemeesterauthor=V.+Suchaudauthor=O.+Taltynovauthor=M.+Billambozauthor=C.+Lionauthor=F.+Baillyauthor=S.+Strelkovauthor=Z.+Debyserauthor=P.+Cotelleauthor=F.+Christ&title=2-Hydroxyisoquinoline-1%2C3%282H%2C4H%29-diones+%28HIDs%29%2C+novel+inhibitors+of+HIV+integrase+with+a+high+barrier+to+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcb4000426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4000426%26sid%3Dliteratum%253Aachs%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DSuchaud%26aufirst%3DV.%26aulast%3DTaltynov%26aufirst%3DO.%26aulast%3DBillamboz%26aufirst%3DM.%26aulast%3DLion%26aufirst%3DC.%26aulast%3DBailly%26aufirst%3DF.%26aulast%3DStrelkov%26aufirst%3DS.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DCotelle%26aufirst%3DP.%26aulast%3DChrist%26aufirst%3DF.%26atitle%3D2-Hydroxyisoquinoline-1%252C3%25282H%252C4H%2529-diones%2520%2528HIDs%2529%252C%2520novel%2520inhibitors%2520of%2520HIV%2520integrase%2520with%2520a%2520high%2520barrier%2520to%2520resistance%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1187%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Billamboz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeulemeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreola, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotelle, P.</span><span> </span><span class="NLM_article-title">4-Substituted 2-hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as a novel class of HIV-1 integrase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400009t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=606-611&author=M.+Billambozauthor=V.+Suchaudauthor=F.+Baillyauthor=C.+Lionauthor=J.+Demeulemeesterauthor=C.+Calmelsauthor=M.-L.+Andreolaauthor=F.+Christauthor=Z.+Debyserauthor=P.+Cotelle&title=4-Substituted+2-hydroxyisoquinoline-1%2C3%282H%2C4H%29-diones+as+a+novel+class+of+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml400009t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400009t%26sid%3Dliteratum%253Aachs%26aulast%3DBillamboz%26aufirst%3DM.%26aulast%3DSuchaud%26aufirst%3DV.%26aulast%3DBailly%26aufirst%3DF.%26aulast%3DLion%26aufirst%3DC.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DCalmels%26aufirst%3DC.%26aulast%3DAndreola%26aufirst%3DM.-L.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DCotelle%26aufirst%3DP.%26atitle%3D4-Substituted%25202-hydroxyisoquinoline-1%252C3%25282H%252C4H%2529-diones%2520as%2520a%2520novel%2520class%2520of%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D606%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stead, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bru, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, R. A.</span><span> </span><span class="NLM_article-title">Discovery of an HIV integrase inhibitor with an excellent resistance profile</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=709-719&author=D.+C.+Prydeauthor=R.+Websterauthor=S.+L.+Butlerauthor=E.+J.+Murrayauthor=K.+Whitbyauthor=C.+Pickfordauthor=M.+Westbyauthor=M.+J.+Palmerauthor=D.+J.+Bullauthor=H.+Vuongauthor=D.+C.+Blakemoreauthor=D.+Steadauthor=C.+Ashcroftauthor=I.+Gardnerauthor=C.+Bruauthor=W.-Y.+Cheungauthor=I.+O.+Robertsauthor=J.+Mortonauthor=R.+A.+Bissell&title=Discovery+of+an+HIV+integrase+inhibitor+with+an+excellent+resistance+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DBull%26aufirst%3DD.%2BJ.%26aulast%3DVuong%26aufirst%3DH.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAshcroft%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DBru%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DW.-Y.%26aulast%3DRoberts%26aufirst%3DI.%2BO.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DBissell%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520an%2520HIV%2520integrase%2520inhibitor%2520with%2520an%2520excellent%2520resistance%2520profile%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D709%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes Stephen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke Terrence, R.,  Jr.</span><span> </span><span class="NLM_article-title">Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-ones and 4,5-dihydroxy-1<i>H</i>-isoindole-1,3(2<i>H</i>)-diones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2714-2717&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=B.+C.+Vuauthor=C.+Marchandauthor=H.+Hughes+Stephenauthor=Y.+Pommierauthor=R.+Burke+Terrence&title=Examination+of+halogen+substituent+effects+on+HIV-1+integrase+inhibitors+derived+from+2%2C3-dihydro-6%2C7-dihydroxy-1H-isoindol-1-ones+and+4%2C5-dihydroxy-1H-isoindole-1%2C3%282H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%2BStephen%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%2BTerrence%26aufirst%3DR.%26atitle%3DExamination%2520of%2520halogen%2520substituent%2520effects%2520on%2520HIV-1%2520integrase%2520inhibitors%2520derived%2520from%25202%252C3-dihydro-6%252C7-dihydroxy-1H-isoindol-1-ones%2520and%25204%252C5-dihydroxy-1H-isoindole-1%252C3%25282H%2529-diones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2714%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghyn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R. F.</span><span> </span><span class="NLM_article-title">Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061169b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1322-1334&author=M.+Flipoauthor=T.+Beghynauthor=V.+Lerouxauthor=I.+Florentauthor=B.+P.+Deprezauthor=R.+F.+Deprez-Poulain&title=Novel+selective+inhibitors+of+the+zinc+plasmodial+aminopeptidase+PfA-M1+as+potential+antimalarial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</span></div><div class="casAuthors">Flipo, Marion; Beghyn, Terence; Leroux, Virginie; Florent, Isabelle; Deprez, Benoit P.; Deprez-Poulain, Rebecca F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteases that are expressed during the erythrocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria.  The authors report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite.  These compds. are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals.  Structure-activity relationships in these series are described.  Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1 (I).  This inhibitor displays good physicochem. and pharmacokinetic properties and a promising antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGZDfeX1vJmLVg90H21EOLACvtfcHk0lhKZzrP-2cjJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFKrs7s%253D&md5=4db507b62dc17d977d0ffd10eb4a74b6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061169b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061169b%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DBeghyn%26aufirst%3DT.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DDeprez%26aufirst%3DB.%2BP.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%2BF.%26atitle%3DNovel%2520selective%2520inhibitors%2520of%2520the%2520zinc%2520plasmodial%2520aminopeptidase%2520PfA-M1%2520as%2520potential%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1322%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nicolaou, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J.</span><span> </span><span class="NLM_article-title">Synthesis of the tricyclic core of eleutherobin and sarcodictyins and total synthesis of sarcodictyin A</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">11353</span><span class="NLM_x">–</span> <span class="NLM_lpage">11354</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja973000g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=11353-11354&author=K.+C.+Nicolaouauthor=J.+Y.+Xuauthor=S.+Kimauthor=T.+Ohshimaauthor=S.+Hosokawaauthor=J.+Pfefferkorn&title=Synthesis+of+the+tricyclic+core+of+eleutherobin+and+sarcodictyins+and+total+synthesis+of+sarcodictyin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja973000g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja973000g%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DHosokawa%26aufirst%3DS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520the%2520tricyclic%2520core%2520of%2520eleutherobin%2520and%2520sarcodictyins%2520and%2520total%2520synthesis%2520of%2520sarcodictyin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D11353%26epage%3D11354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rylander, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpenko, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pond, G. R.</span><span> </span><span class="NLM_article-title">Selectivity of hydrogenation over platinum metal catalysts: nitroaromatics</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1970&pages=266-275&author=P.+N.+Rylanderauthor=I.+M.+Karpenkoauthor=G.+R.+Pond&title=Selectivity+of+hydrogenation+over+platinum+metal+catalysts%3A+nitroaromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRylander%26aufirst%3DP.%2BN.%26aulast%3DKarpenko%26aufirst%3DI.%2BM.%26aulast%3DPond%26aufirst%3DG.%2BR.%26atitle%3DSelectivity%2520of%2520hydrogenation%2520over%2520platinum%2520metal%2520catalysts%253A%2520nitroaromatics%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1970%26volume%3D172%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Takenaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyosu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, H.</span><span> </span><span class="NLM_article-title">Selective synthesis of N-aryl hydroxylamines by the hydrogenation of nitroaromatics using supported platinum catalysts</span> <span class="citation_source-journal">Green Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1039%2Fb904672k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1385-1390&author=Y.+Takenakaauthor=T.+Kiyosuauthor=J.-C.+Choiauthor=T.+Sakakuraauthor=H.+Yasuda&title=Selective+synthesis+of+N-aryl+hydroxylamines+by+the+hydrogenation+of+nitroaromatics+using+supported+platinum+catalysts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective synthesis of N-aryl hydroxylamines by the hydrogenation of nitroaromatics using supported platinum catalysts</span></div><div class="casAuthors">Takenaka, Yasumasa; Kiyosu, Takahiro; Choi, Jun-Chul; Sakakura, Toshiyasu; Yasuda, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1385-1390</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Various substituted nitroaroms. were successfully hydrogenated to the corresponding N-aryl hydroxylamines in excellent yields (up to 99%) using supported platinum catalysts such as Pt/SiO2 under a hydrogen atm. (1 bar) at room temp.  The key to the fast and highly selective formation of hydroxylamines is the addn. of small amts. of amines such as triethylamine and DMSO; amines promote the conversion of nitroaroms., while DMSO inhibits further hydrogenation of hydroxylamines to anilines.  The promotive effect depends on which type of amine and primary amine was most effective.  The hydrogenation efficiently proceeded in common org. solvents, including isopropanol, di-Et ether, and acetone.  This methodol. should extend the application range of conventional solid catalysts to fine chems. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxpTvDQQKJ67Vg90H21EOLACvtfcHk0lhKZzrP-2cjJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtbjK&md5=903b72ed82c1b4a7171fed7cbfc305bf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fb904672k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904672k%26sid%3Dliteratum%253Aachs%26aulast%3DTakenaka%26aufirst%3DY.%26aulast%3DKiyosu%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DJ.-C.%26aulast%3DSakakura%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DH.%26atitle%3DSelective%2520synthesis%2520of%2520N-aryl%2520hydroxylamines%2520by%2520the%2520hydrogenation%2520of%2520nitroaromatics%2520using%2520supported%2520platinum%2520catalysts%26jtitle%3DGreen%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D1385%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 Integrase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7309</span><span class="NLM_x">–</span> <span class="NLM_lpage">7313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7309-7313&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=S.+J.+Smithauthor=M.+Metifiotauthor=B.+Johnsonauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=6%2C7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing+HIV-1+Integrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D6%252C7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing%2520HIV-1%2520Integrase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7309%26epage%3D7313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Williams, P. D.; Venkatraman, S.; Langford, H. M.; Kim, B.; Booth, T. M.; Grobler, J. A.; Staas, D.; Ruzek, R. D.; Embrey, M. W.; Wiscount, C. M.; Lyle, T. A.</span><span> </span><span class="NLM_article-title">Preparation of 1-Hydroxynaphthyridin-2(1<i>H</i>)-one Derivatives as Anti-HIV Agents</span>. Patent WO2008010964(A1).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Williams%2C+P.+D.%3B+Venkatraman%2C+S.%3B+Langford%2C+H.+M.%3B+Kim%2C+B.%3B+Booth%2C+T.+M.%3B+Grobler%2C+J.+A.%3B+Staas%2C+D.%3B+Ruzek%2C+R.+D.%3B+Embrey%2C+M.+W.%3B+Wiscount%2C+C.+M.%3B+Lyle%2C+T.+A.+Preparation+of+1-Hydroxynaphthyridin-2%281H%29-one+Derivatives+as+Anti-HIV+Agents.+Patent+WO2008010964%28A1%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%25201-Hydroxynaphthyridin-2%25281H%2529-one%2520Derivatives%2520as%2520Anti-HIV%2520Agents" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">2,3-Dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-one-based HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=251-259&author=X.+Z.+Zhaoauthor=E.+A.+Semenovaauthor=B.+C.+Vuauthor=K.+Maddaliauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=2%2C3-Dihydro-6%2C7-dihydroxy-1H-isoindol-1-one-based+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070715d%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSemenova%26aufirst%3DE.%2BA.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D2%252C3-Dihydro-6%252C7-dihydroxy-1H-isoindol-1-one-based%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valantin, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peytavin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span> </span><span class="NLM_article-title">Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1351-1358&author=I.+Maletauthor=O.+Delelisauthor=M.-A.+Valantinauthor=B.+Montesauthor=C.+Soulieauthor=M.+Wirdenauthor=L.+Tchertanovauthor=G.+Peytavinauthor=J.+Reynesauthor=J.-F.+Mouscadetauthor=C.+Katlamaauthor=V.+Calvezauthor=A.-G.+Marcelin&title=Mutations+associated+with+failure+of+raltegravir+treatment+affect+integrase+sensitivity+to+the+inhibitor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DValantin%26aufirst%3DM.-A.%26aulast%3DMontes%26aufirst%3DB.%26aulast%3DSoulie%26aufirst%3DC.%26aulast%3DWirden%26aufirst%3DM.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DPeytavin%26aufirst%3DG.%26aulast%3DReynes%26aufirst%3DJ.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26atitle%3DMutations%2520associated%2520with%2520failure%2520of%2520raltegravir%2520treatment%2520affect%2520integrase%2520sensitivity%2520to%2520the%2520inhibitor%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1351%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3715</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi100130f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3715-3722&author=M.+Metifiotauthor=K.+Maddaliauthor=A.+Naumovaauthor=X.+Zhangauthor=C.+Marchandauthor=Y.+Pommier&title=Biochemical+and+pharmacological+analyses+of+HIV-1+integrase+flexible+loop+mutants+resistant+to+raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi100130f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100130f%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DBiochemical%2520and%2520pharmacological%2520analyses%2520of%2520HIV-1%2520integrase%2520flexible%2520loop%2520mutants%2520resistant%2520to%2520raltegravir%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3715%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mesplede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quashie, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Resistance to HIV integrase inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1097%2FCOH.0b013e328356db89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22789986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=401-408&author=T.+Mespledeauthor=P.+K.+Quashieauthor=M.+A.+Wainberg&title=Resistance+to+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to HIV integrase inhibitors</span></div><div class="casAuthors">Mesplede, Thibault; Quashie, Peter K.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: HIV integrase inhibitors are potent antiretroviral drugs that efficiently decrease viral load in patients.  Emergence of resistance mutations against this new class of drugs represents a threat to their long-term efficacy.  The purpose of this review is to provide new information about the most recent mutations identified and other mutations that confer resistance to several integrase inhibitors.  Recent findings: New resistance mutations, such as G118R, R263K and S153Y, have been recently identified through in-vitro selection studies with second-generation integrase strand-transfer inhibitors (INSTIs).  These add to the three main resistance pathways involving mutations at positions Y143, N155 and Q148.  Structural modeling, biochem. analyses and deep sequencing are methods that currently help in the understanding of the mechanisms of resistance conferred by these mutations.  Although these new resistance mutations appear to confer only low levels of cross-resistance to second-generation drugs, the Q148 pathway with numerous secondary mutations has the potential to significantly decrease susceptibility to all drugs of the INSTI family.  Summary: Recent mutations selected in vitro with second-generation INSTIs suggest the existence of low levels of cross-resistance between these drugs and first-generation compds.  In clin. practice, the emergence of mutations at position Q148 should be monitored whenever possible.  More datasets are needed to assess the long-term efficacy of second-generation INSTIs in patients failing older INSTIs such as raltegravir and elvitegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsULhoKhjr9bVg90H21EOLACvtfcHk0ljTzmern5vV6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO&md5=aea851c3b23668be783f7584cb9e9507</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e328356db89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e328356db89%26sid%3Dliteratum%253Aachs%26aulast%3DMesplede%26aufirst%3DT.%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DResistance%2520to%2520HIV%2520integrase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2012%26volume%3D7%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Bicyclic hydroxy-1<i>H</i>-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1111%2Fj.1747-0285.2011.01270.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=157-165&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=M.+Metifiotauthor=S.+J.+Smithauthor=B.+C.+Vuauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=Bicyclic+hydroxy-1H-pyrrolopyridine-trione+containing+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span></div><div class="casAuthors">Zhao, Xue Zhi; Maddali, Kasthuraiah; Metifiot, Mathieu; Smith, Steven J.; Vu, B. Christie; Marchand, Christophe; Hughes, Stephen H.; Pommier, Yves; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 integrase (IN) is a validated therapeutic target for the treatment of AIDS.  However, the emergence of resistance to raltegravir, the sole marketed FDA-approved IN inhibitor, emphasizes the need to develop second-generation inhibitors that retain efficacy against clin. relevant IN mutants.  We report herein bicyclic hydroxy-1H-pyrrolopyridinetriones as a new family of HIV-1 integrase inhibitors that were efficiently prepd. using a key "Pummerer cyclization deprotonation cycloaddn." cascade of imidosulfoxides.  In in vitro HIV-1 integrase assays, the analogs showed low micromolar inhibitory potencies with selectivity for strand transfer reactions as compared with 3'-processing inhibition.  A representative chlorofluorobenzyl hydroxypyrrolopyridinetrione retained most of its inhibitory potency against the three major raltegravir-resistant IN mutant enzymes, G140S/Q148H, Y143R, and N155H.  In antiviral assays employing viral vectors coding these IN mutants, the chlorofluorobenzyl hydroxypyrrolopyridinetrione was approx. 200- and 20-fold less affected than raltegravir against the G140S/Q148H and Y143R mutations, resp.  The representative chlorofluorobenzyl hydroxypyrrolopyridinetrione was affected approx. 10-fold less by the N155H mutation than raltegravir.  Hydroxypyrrolopyridinetriones are a novel structural class that may be further optimized to obtain HIV-1 integrase inhibitors capable of overcoming raltegravir resistance in HIV-1 strains possessing G140S/Q148H mutations in HIV-1 integrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-V1xazfn1LVg90H21EOLACvtfcHk0lgCcWZFu9mr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D&md5=467e940ff1b737e55486e8f578db6da0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01270.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01270.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DBicyclic%2520hydroxy-1H-pyrrolopyridine-trione%2520containing%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Brachmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldbruegge, M.</span><span> </span><span class="NLM_article-title">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span> <span class="citation_source-journal">Mol. Genet. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1007%2Fs00438-004-1067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=15316769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2004&pages=216-226&author=A.+Brachmannauthor=J.+Koenigauthor=C.+Juliusauthor=M.+Feldbruegge&title=A+reverse+genetic+approach+for+generating+gene+replacement+mutants+in+Ustilago+maydis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span></div><div class="casAuthors">Brachmann, A.; Koenig, J.; Julius, C.; Feldbruegge, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-226</span>CODEN:
                <span class="NLM_cas:coden">MGGOAA</span>;
        ISSN:<span class="NLM_cas:issn">1617-4615</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We describe a versatile strategy for generating gene replacement mutants in the phytopathogenic fungus Ustilago maydis.  The system includes the choice of 32 different insertion cassettes for genetic engineering purposes, such as gene disruption and more sophisticated insertions of reporter genes, heterologous promoters or combinations of the two.  PCR-amplified flanking sequences needed for homologous recombination are ligated to the resp. insertion cassettes via Sfi I sites.  As proof of principle we generated two replacement mutants in which the endogenous promoter of the pheromone gene mfa1 drives expression of the Green Fluorescent Protein gene (gfp).  Simultaneously, expression of the mfa1 ORF is controlled either by the carbon source-regulated crg1 promoter or the nitrogen source-regulated nar1 promoter.  In both cases gfp expression was pheromone-inducible and pheromone expression was only detected when the heterologous promoters were active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckY_KQd6m37Vg90H21EOLACvtfcHk0lgCcWZFu9mr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D&md5=ae76faf1e45e14ef570b2cf60e8d67a3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00438-004-1067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00438-004-1067-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrachmann%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DJ.%26aulast%3DJulius%26aufirst%3DC.%26aulast%3DFeldbruegge%26aufirst%3DM.%26atitle%3DA%2520reverse%2520genetic%2520approach%2520for%2520generating%2520gene%2520replacement%2520mutants%2520in%2520Ustilago%2520maydis%26jtitle%3DMol.%2520Genet.%2520Genomics%26date%3D2004%26volume%3D272%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Maskell</span>, <span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Valerie E.  Pye</span>, <span class="hlFld-ContribAuthor ">Katherine  Fesen</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Peter  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7315-7332. <a href="https://doi.org/10.1021/acs.jmedchem.7b00596" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BOptimization%252Bof%252BHIV%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24042017%26date%3D10082017%26date%3D14092017%26date%3D24072017%26volume%3D60%26issue%3D17%26spage%3D7315%26epage%3D7332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Maskell</span>, <span class="hlFld-ContribAuthor ">Mathieu  Metifiot</span>, <span class="hlFld-ContribAuthor ">Valerie E.  Pye</span>, <span class="hlFld-ContribAuthor ">Katherine  Fesen</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Peter  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (4)
                                     , 1074-1081. <a href="https://doi.org/10.1021/acschembio.5b00948" title="DOI URL">https://doi.org/10.1021/acschembio.5b00948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00948%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DHIV-1%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%252Bwith%252BReduced%252BSusceptibility%252Bto%252BDrug%252BResistant%252BMutant%252BIntegrases%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D17112015%26date%3D25012016%26date%3D05022016%26date%3D15042016%26date%3D25012016%26volume%3D11%26issue%3D4%26spage%3D1074%26epage%3D1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Paul L.  Boyer</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5190-5202. <a href="https://doi.org/10.1021/jm5001908" title="DOI URL">https://doi.org/10.1021/jm5001908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5001908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5001908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Amino-1-hydroxy-2-oxo-1%25252C8-naphthyridine-Containing%252BCompounds%252BHaving%252BHigh%252BPotency%252Bagainst%252BRaltegravir-Resistant%252BIntegrase%252BMutants%252Bof%252BHIV-1%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D04022014%26date%3D16062014%26date%3D26062014%26date%3D05062014%26volume%3D57%26issue%3D12%26spage%3D5190%26epage%3D5202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilona K.  Jóźwik</span>, <span class="hlFld-ContribAuthor ">Dario O.  Passos</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lyumkis</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Biology of HIV Integrase Strand Transfer Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2020,</strong> <em>41 </em>
                                    (9)
                                     , 611-626. <a href="https://doi.org/10.1016/j.tips.2020.06.003" title="DOI URL">https://doi.org/10.1016/j.tips.2020.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DStructural%252BBiology%252Bof%252BHIV%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%26aulast%3DJ%25C3%25B3%25C5%25BAwik%26aufirst%3DIlona%2BK.%26date%3D2020%26volume%3D41%26issue%3D9%26spage%3D611%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasily N.  Osipov</span>, <span class="hlFld-ContribAuthor ">Derenik S.  Khachatryan</span>, <span class="hlFld-ContribAuthor ">Alexandr N.  Balaev</span>. </span><span class="cited-content_cbyCitation_article-title">Biologically active quinazoline-based hydroxamic acids. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (5)
                                     , 831-845. <a href="https://doi.org/10.1007/s00044-020-02530-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02530-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02530-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02530-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DBiologically%252Bactive%252Bquinazoline-based%252Bhydroxamic%252Bacids%26aulast%3DOsipov%26aufirst%3DVasily%2BN.%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D5%26spage%3D831%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Márcio W.  Paixão</span>, <span class="hlFld-ContribAuthor ">Rafaely N.  Lima</span>, <span class="hlFld-ContribAuthor ">Camila M.  Kisukuri</span>, <span class="hlFld-ContribAuthor ">Priscilla M.  Matos</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridines and Their Benzo Derivatives: Reactivity of Reduced Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00012-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00012-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00012-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00012-3%26sid%3Dliteratum%253Aachs%26atitle%3DPyridines%252Band%252BTheir%252BBenzo%252BDerivatives%25253A%252BReactivity%252Bof%252BReduced%252BCompounds%26aulast%3DPaix%25C3%25A3o%26aufirst%3DM%25C3%25A1rcio%2BW.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenling  Niu</span>, <span class="hlFld-ContribAuthor ">Tang  Tang</span>, <span class="hlFld-ContribAuthor ">Chengfei  Hou</span>, <span class="hlFld-ContribAuthor ">Yajie  Guo</span>, <span class="hlFld-ContribAuthor ">Ren  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">A Strategy to Find Novel Candidate DKAs Inhibitors Using Modified QSAR Model with Favorable Druggability Properties. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2019,</strong> <em>35 </em>
                                    (6)
                                     , 1111-1118. <a href="https://doi.org/10.1007/s40242-019-9183-5" title="DOI URL">https://doi.org/10.1007/s40242-019-9183-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-019-9183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-019-9183-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DA%252BStrategy%252Bto%252BFind%252BNovel%252BCandidate%252BDKAs%252BInhibitors%252BUsing%252BModified%252BQSAR%252BModel%252Bwith%252BFavorable%252BDruggability%252BProperties%26aulast%3DZhang%26aufirst%3DXiaoyi%26date%3D2019%26date%3D2019%26volume%3D35%26issue%3D6%26spage%3D1111%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruo  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Xu</span>, <span class="hlFld-ContribAuthor ">Weixiong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolone derivatives: Potential anti‐HIV agent—development and application. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (9)
                                     , 1900045. <a href="https://doi.org/10.1002/ardp.201900045" title="DOI URL">https://doi.org/10.1002/ardp.201900045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900045%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DQuinolone%252Bderivatives%25253A%252BPotential%252Banti%2525E2%252580%252590HIV%252Bagent%2525E2%252580%252594development%252Band%252Bapplication%26aulast%3DWang%26aufirst%3DRuo%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D9%26spage%3D1900045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Ha T.  Do</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 390-399. <a href="https://doi.org/10.1016/j.ejmech.2019.01.081" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.081%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore-based%252Bdesign%252Bof%252Bnovel%252B3-hydroxypyrimidine-2%25252C4-dione%252Bsubtypes%252Bas%252Binhibitors%252Bof%252BHIV%252Breverse%252Btranscriptase-associated%252BRNase%252BH%25253A%252BTolerance%252Bof%252Ba%252Bnonflexible%252Blinker%26aulast%3DTang%26aufirst%3DJing%26date%3D2019%26volume%3D166%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2018,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-018-0420-7" title="DOI URL">https://doi.org/10.1186/s12977-018-0420-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-018-0420-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-018-0420-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DEfficacies%252Bof%252BCabotegravir%252Band%252BBictegravir%252Bagainst%252Bdrug-resistant%252BHIV-1%252Bintegrase%252Bmutants%26aulast%3DSmith%26aufirst%3DSteven%2BJ.%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eungi  Choi</span>, <span class="hlFld-ContribAuthor ">Jayapal Reddy  Mallareddy</span>, <span class="hlFld-ContribAuthor ">Dai  Lu</span>, <span class="hlFld-ContribAuthor ">Srikanth  Kolluru</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase. </span><span class="cited-content_cbyCitation_journal-name">Future Science OA</span><span> <strong>2018,</strong> <em>4 </em>
                                    (9)
                                     , FSO338. <a href="https://doi.org/10.4155/fsoa-2018-0060" title="DOI URL">https://doi.org/10.4155/fsoa-2018-0060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fsoa-2018-0060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffsoa-2018-0060%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Science%2520OA%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall-molecule%252Binhibitors%252Bof%252BHIV-1%252Bintegrase%26aulast%3DChoi%26aufirst%3DEungi%26date%3D2018%26volume%3D4%26issue%3D9%26spage%3DFSO338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Guanyu  Dong</span>, <span class="hlFld-ContribAuthor ">Xujie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xueshun  Wang</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 714-724. <a href="https://doi.org/10.1016/j.ejmech.2018.06.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Hydroxypyrido%25255B2%25252C3-b%25255Dpyrazin-6%2525285H%252529-one%252Bderivatives%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase-associated%252Bribonuclease%252BH%252Band%252Bintegrase%26aulast%3DSun%26aufirst%3DLin%26date%3D2018%26volume%3D155%26spage%3D714%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul L.  Boyer</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kalyan  Das</span>, <span class="hlFld-ContribAuthor ">Kevin  Gruber</span>, <span class="hlFld-ContribAuthor ">Eddy  Arnold</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, . </span><span class="cited-content_cbyCitation_article-title">Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2018,</strong> <em>92 </em>
                                    (13)
                                     <a href="https://doi.org/10.1128/JVI.02203-17" title="DOI URL">https://doi.org/10.1128/JVI.02203-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.02203-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.02203-17%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DDeveloping%252Band%252BEvaluating%252BInhibitors%252Bagainst%252Bthe%252BRNase%252BH%252BActive%252BSite%252Bof%252BHIV-1%252BReverse%252BTranscriptase%26aulast%3DBoyer%26aufirst%3DPaul%2BL.%26date%3D2018%26volume%3D92%26issue%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niloofar  Parizadeh</span>, <span class="hlFld-ContribAuthor ">Eskandar  Alipour</span>, <span class="hlFld-ContribAuthor ">Sepehr  Soleymani</span>, <span class="hlFld-ContribAuthor ">Rezvan  Zabihollahi</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Aghasadeghi</span>, <span class="hlFld-ContribAuthor ">Zahra  Hajimahdi</span>, <span class="hlFld-ContribAuthor ">Afshin  Zarghi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel 3-(5-(Alkyl/arylthio)-1,3,4-Oxadiazol-2-yl)-8-Phenylquinolin-4(1
              H
              )-One Derivatives as Anti-HIV Agents. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2018,</strong> <em>193 </em>
                                    (4)
                                     , 225-231. <a href="https://doi.org/10.1080/10426507.2017.1394302" title="DOI URL">https://doi.org/10.1080/10426507.2017.1394302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2017.1394302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2017.1394302%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DSynthesis%252Bof%252BNovel%252B3-%2525285-%252528Alkyl%25252Farylthio%252529-1%25252C3%25252C4-Oxadiazol-2-yl%252529-8-Phenylquinolin-4%2525281%252BH%252B%252529-One%252BDerivatives%252Bas%252BAnti-HIV%252BAgents%26aulast%3DParizadeh%26aufirst%3DNiloofar%26date%3D2018%26date%3D2017%26volume%3D193%26issue%3D4%26spage%3D225%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongli  Duan</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Hehua  Xiong</span>, <span class="hlFld-ContribAuthor ">Linxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Bingbing  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Caolin  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Peng</span>, <span class="hlFld-ContribAuthor ">Shifan  Cai</span>, <span class="hlFld-ContribAuthor ">Rong  Luo</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Qidong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 2-substituted-4-phenoxypyridine derivatives as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 254-259. <a href="https://doi.org/10.1016/j.bmcl.2017.12.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252B2-substituted-4-phenoxypyridine%252Bderivatives%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DDuan%26aufirst%3DYongli%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D254%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidong  Tang</span>, <span class="hlFld-ContribAuthor ">Yongli  Duan</span>, <span class="hlFld-ContribAuthor ">Linxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqiang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Caolin  Wang</span>, <span class="hlFld-ContribAuthor ">Han  Mei</span>, <span class="hlFld-ContribAuthor ">Sheng  Tang</span>, <span class="hlFld-ContribAuthor ">Yinhua  Xiong</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 266-275. <a href="https://doi.org/10.1016/j.ejmech.2017.11.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252Bpyrrolo%25255B2%25252C3-b%25255Dpyridine%252Bderivatives%252Bbearing%252Bthe%252B1%25252C8-naphthyridin-2-one%252Bmoiety%26aulast%3DTang%26aufirst%3DQidong%26date%3D2018%26volume%3D143%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sunetra J.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Reshma B.  Patil</span>, <span class="hlFld-ContribAuthor ">Digambar R.  Kumbhar</span>, <span class="hlFld-ContribAuthor ">Ajinkya A.  Patravale</span>, <span class="hlFld-ContribAuthor ">Dattatraya R.  Chandam</span>, <span class="hlFld-ContribAuthor ">Madhukar B.  Deshmukh</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfamic acid-catalyzed multicomponent synthesis of 7-phenyl-7,12 dihydrobenzo(h)pyrido[2,3-b]naphthydrin-6(5H)-one derivatives: a green avenue. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (4)
                                     , 2529-2543. <a href="https://doi.org/10.1007/s11164-016-2778-2" title="DOI URL">https://doi.org/10.1007/s11164-016-2778-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2778-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2778-2%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSulfamic%252Bacid-catalyzed%252Bmulticomponent%252Bsynthesis%252Bof%252B7-phenyl-7%25252C12%252Bdihydrobenzo%252528h%252529pyrido%25255B2%25252C3-b%25255Dnaphthydrin-6%2525285H%252529-one%252Bderivatives%25253A%252Ba%252Bgreen%252Bavenue%26aulast%3DJadhav%26aufirst%3DSunetra%2BJ.%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D4%26spage%3D2529%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.E.  Lazerwith</span>, <span class="hlFld-ContribAuthor ">D.  Siegel</span>, <span class="hlFld-ContribAuthor ">R.M.  McFadden</span>, <span class="hlFld-ContribAuthor ">M.R.  Mish</span>, <span class="hlFld-ContribAuthor ">W.C.  Tse</span>. </span><span class="cited-content_cbyCitation_article-title">New Antiretrovirals for HIV and Antivirals for HBV. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 628-664. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12407-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12407-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12407-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12407-2%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BAntiretrovirals%252Bfor%252BHIV%252Band%252BAntivirals%252Bfor%252BHBV%26aulast%3DLazerwith%26aufirst%3DS.E.%26date%3D2017%26spage%3D628%26epage%3D664%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janani  Varadarajan</span>, <span class="hlFld-ContribAuthor ">Mary Jane  McWilliams</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Mott</span>, <span class="hlFld-ContribAuthor ">Craig J.  Thomas</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Drug resistant integrase mutants cause aberrant HIV integrations. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2016,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-016-0305-6" title="DOI URL">https://doi.org/10.1186/s12977-016-0305-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-016-0305-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-016-0305-6%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DDrug%252Bresistant%252Bintegrase%252Bmutants%252Bcause%252Baberrant%252BHIV%252Bintegrations%26aulast%3DVaradarajan%26aufirst%3DJanani%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guan-Nan  Liu</span>, <span class="hlFld-ContribAuthor ">Rong-Hua  Luo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Xing-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Liu-Meng  Yang</span>, <span class="hlFld-ContribAuthor ">Yong-Tang  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HIV-1 Activity Evaluation for Novel 3a,6a-Dihydro-1H-pyrrolo[3,4-c]pyrazole-4,6-dione Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (9)
                                     , 1198. <a href="https://doi.org/10.3390/molecules21091198" title="DOI URL">https://doi.org/10.3390/molecules21091198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21091198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21091198%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAnti-HIV-1%252BActivity%252BEvaluation%252Bfor%252BNovel%252B3a%25252C6a-Dihydro-1H-pyrrolo%25255B3%25252C4-c%25255Dpyrazole-4%25252C6-dione%252BDerivatives%26aulast%3DLiu%26aufirst%3DGuan-Nan%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D9%26spage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Barry C.  Johnson</span>, <span class="hlFld-ContribAuthor ">Evgeny  Kiselev</span>, <span class="hlFld-ContribAuthor ">Laura  Marler</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2016,</strong> <em>44 </em>
                                    (14)
                                     , 6896-6906. <a href="https://doi.org/10.1093/nar/gkw592" title="DOI URL">https://doi.org/10.1093/nar/gkw592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkw592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkw592%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DSelectivity%252Bfor%252Bstrand-transfer%252Bover%252B3%2525E2%252580%2525B2-processing%252Band%252Bsusceptibility%252Bto%252Bclinical%252Bresistance%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%252Bare%252Bdriven%252Bby%252Bkey%252Benzyme%2525E2%252580%252593DNA%252Binteractions%252Bin%252Bthe%252Bactive%252Bsite%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DMathieu%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D14%26spage%3D6896%26epage%3D6906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin-Bin  Feng</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Green Synthesis of Fused Polycyclic Pyrazolo[3,4-
              b
              ][1,6]naphthyridine Derivatives in Ionic Liquids via Three-Component Reaction. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2016,</strong> <em>36 </em>
                                    (4)
                                     , 478-489. <a href="https://doi.org/10.1080/10406638.2015.1014969" title="DOI URL">https://doi.org/10.1080/10406638.2015.1014969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2015.1014969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2015.1014969%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DGreen%252BSynthesis%252Bof%252BFused%252BPolycyclic%252BPyrazolo%25255B3%25252C4-%252Bb%252B%25255D%25255B1%25252C6%25255Dnaphthyridine%252BDerivatives%252Bin%252BIonic%252BLiquids%252Bvia%252BThree-Component%252BReaction%26aulast%3DFeng%26aufirst%3DBin-Bin%26date%3D2016%26date%3D2015%26volume%3D36%26issue%3D4%26spage%3D478%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Gang  Ma</span>, <span class="hlFld-ContribAuthor ">Wen-Wen  Qiang</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed Ullmann reaction for the synthesis of fused hexacyclic heterocycles containing naphthyridine, acridine, and pyrazole (imidazole) moieties. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2016,</strong> <em>147 </em>
                                    (7)
                                     , 1233-1242. <a href="https://doi.org/10.1007/s00706-015-1625-2" title="DOI URL">https://doi.org/10.1007/s00706-015-1625-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-015-1625-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-015-1625-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DCopper-catalyzed%252BUllmann%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bfused%252Bhexacyclic%252Bheterocycles%252Bcontaining%252Bnaphthyridine%25252C%252Bacridine%25252C%252Band%252Bpyrazole%252B%252528imidazole%252529%252Bmoieties%26aulast%3DMa%26aufirst%3DYong-Gang%26date%3D2016%26date%3D2016%26volume%3D147%26issue%3D7%26spage%3D1233%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravan K.  Thummanapelli</span>, <span class="hlFld-ContribAuthor ">Seyedmorteza  Hosseyni</span>, <span class="hlFld-ContribAuthor ">Yijin  Su</span>, <span class="hlFld-ContribAuthor ">Novruz G.  Akhmedov</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-controlled gold-catalyzed cycloisomerization of 1,n-enyne esters toward synthesis of dihydronaphthalene. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (49)
                                     , 7687-7690. <a href="https://doi.org/10.1039/C6CC03032G" title="DOI URL">https://doi.org/10.1039/C6CC03032G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC03032G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC03032G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DLigand-controlled%252Bgold-catalyzed%252Bcycloisomerization%252Bof%252B1%25252Cn-enyne%252Besters%252Btoward%252Bsynthesis%252Bof%252Bdihydronaphthalene%26aulast%3DThummanapelli%26aufirst%3DSravan%2BK.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D49%26spage%3D7687%26epage%3D7690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alka  Madaan</span>, <span class="hlFld-ContribAuthor ">Ritu  Verma</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Anu T.  Singh</span>, <span class="hlFld-ContribAuthor ">Swatantra K.  Jain</span>, <span class="hlFld-ContribAuthor ">Manu  Jaggi</span>. </span><span class="cited-content_cbyCitation_article-title">1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (12)
                                     , 837-860. <a href="https://doi.org/10.1002/ardp.201500237" title="DOI URL">https://doi.org/10.1002/ardp.201500237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500237%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D1%25252C8-Naphthyridine%252BDerivatives%25253A%252BA%252BReview%252Bof%252BMultiple%252BBiological%252BActivities%26aulast%3DMadaan%26aufirst%3DAlka%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D12%26spage%3D837%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Gang  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Newly approved integrase inhibitors for clinical treatment of AIDS. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2014,</strong> <em>68 </em>
                                    (8)
                                     , 917-921. <a href="https://doi.org/10.1016/j.biopha.2014.09.013" title="DOI URL">https://doi.org/10.1016/j.biopha.2014.09.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2014.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2014.09.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DNewly%252Bapproved%252Bintegrase%252Binhibitors%252Bfor%252Bclinical%252Btreatment%252Bof%252BAIDS%26aulast%3DGu%26aufirst%3DWan-Gang%26date%3D2014%26volume%3D68%26issue%3D8%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Han</span>, <span class="hlFld-ContribAuthor ">Haoming  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Po  Tien</span>, <span class="hlFld-ContribAuthor ">Shuwen  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SARs of indole-based α-amino acids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (41)
                                     , 8308-8317. <a href="https://doi.org/10.1039/C4OB01333F" title="DOI URL">https://doi.org/10.1039/C4OB01333F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01333F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01333F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DSynthesis%252Band%252BSARs%252Bof%252Bindole-based%252B%2525CE%2525B1-amino%252Bacids%252Bas%252Bpotent%252BHIV-1%252Bnon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%26aulast%3DHan%26aufirst%3DXin%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D41%26spage%3D8308%26epage%3D8317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HIV-1 integrase inhibitors discussed in the text. Mg<sup>2+</sup>-chelating heteroatoms are shown in red with the halogen-substituted aromatic functionality shown in blue. The amide linkers are shown in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Analogues <b>6a</b>–<b>c</b> and <b>12c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HOAc (4 equiv), CH<sub>2</sub>(CO<sub>2</sub>Me)<sub>2</sub> or CH<sub>2</sub>(CO<sub>2</sub>Et)<sub>2</sub> (12 equiv), piperidine (1.2 equiv), microwave, 80 °C; (ii) H<sub>2</sub>, PtO<sub>2</sub> (0.15 equiv), rt; (iii) 3-Cl-4-F-BnNH<sub>2</sub> (a), 3,4-diF-BnNH<sub>2</sub> (b) or 2,4-diF-BnNH<sub>2</sub> (c), 60 °C; iv) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/medium/jm-2013-01902n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>7a</b>–<b>c</b> and <b>8a</b>–<b>c</b> and Over-reduced Products <b>20a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-4/jm401902n/20150128/images/large/jm-2013-01902n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401902n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnONH<sub>2</sub>, DMSO, 140 °C; (ii) ClCOCH<sub>2</sub>CO<sub>2</sub>CH<sub>3</sub>, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (iii) NaOMe, MeOH, rt; (iv) Tf<sub>2</sub>O, 0 °C; (v) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, TIS, NEt<sub>3</sub>, 85 °C; (vi) (a) 3-Cl-4-F-BnNH<sub>2</sub>, (b) 3,4-diF-BnNH<sub>2</sub>, or (c) 2,4-diF-BnNH<sub>2</sub>; (vii) H<sub>2</sub>, Pd·C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: 20-Year landmark and challenges</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=75-105&author=M.+Metifiotauthor=C.+Marchandauthor=Y.+Pommier&title=HIV+integrase+inhibitors%3A+20-Year+landmark+and+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%252020-Year%2520landmark%2520and%2520challenges%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2013%26volume%3D67%26spage%3D75%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">Inhibiting the HIV integration process: past, present, and the future</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm400674a</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400674a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Di+Santo&title=Inhibiting+the+HIV+integration+process%3A+past%2C+present%2C+and+the+future&doi=10.1021%2Fjm400674a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm400674a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400674a%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DInhibiting%2520the%2520HIV%2520integration%2520process%253A%2520past%252C%2520present%252C%2520and%2520the%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400674a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. J.</span><span> </span><span class="NLM_article-title">Raltegravir: In treatment-naive patients with HIV-1 infection</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=631-642&author=J.+D.+Croxtallauthor=L.+J.+Scott&title=Raltegravir%3A+In+treatment-naive+patients+with+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DScott%26aufirst%3DL.%2BJ.%26atitle%3DRaltegravir%253A%2520In%2520treatment-naive%2520patients%2520with%2520HIV-1%2520infection%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D631%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wills, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V.</span><span> </span><span class="NLM_article-title">Elvitegravir: A once-daily inhibitor of HIV-1 integrase</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=395-401&author=T.+Willsauthor=V.+Vega&title=Elvitegravir%3A+A+once-daily+inhibitor+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills%26aufirst%3DT.%26aulast%3DVega%26aufirst%3DV.%26atitle%3DElvitegravir%253A%2520A%2520once-daily%2520inhibitor%2520of%2520HIV-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV-1 IN inhibitors: 2010 Update and perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.2174%2F156802609789630910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=19747122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1016-1037&author=C.+Marchandauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Pommier&title=HIV-1+IN+inhibitors%3A+2010+Update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 IN inhibitors: 2010 update and perspectives</span></div><div class="casAuthors">Marchand, Christophe; Maddali, Kasthuraiah; Metifiot, Mathieu; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1016-1037</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is the newest validated target against AIDS and retroviral infections.  The remarkable activity of raltegravir (Isentress) led to its rapid approval by the FDA in 2007 as the first IN inhibitor.  Several other IN strand transfer inhibitors (STIs) are in development with the primary goal to overcome resistance due to the rapid occurrence of IN mutations in raltegravir-treated patients.  Thus, many scientists and drug companies are actively pursuing clin. useful IN inhibitors.  The objective of this review is to provide an update on the IN inhibitors reported in the last two years, including second generation STI, recently developed hydroxylated aroms., natural products, peptide, antibody and oligonucleotide inhibitors.  Addnl., the targeting of IN cofactors such as LEDGF and Vpr will be discussed as novel strategies for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpn7mNYPX9bVg90H21EOLACvtfcHk0ljLqpCIb6bSYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN&md5=f1820ab6d7faa583030f4fd5c6872acb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802609789630910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630910%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV-1%2520IN%2520inhibitors%253A%25202010%2520Update%2520and%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1016%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Resistance to integrase inhibitors</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.3390%2Fv2071347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=20706558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1anu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1347-1366&author=M.+Metifiotauthor=C.+Marchandauthor=K.+Maddaliauthor=Y.+Pommier&title=Resistance+to+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to integrase inhibitors</span></div><div class="casAuthors">Metifiot, Mathieu; Marchand, Christophe; Maddali, Kasthuraiah; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1347-1366</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is a clin. validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clin. activity.  The next most advanced IN inhibitor is elvitegravir.  However, mutant viruses lead to treatment failure and mutations within the IN coding sequence appear to confer cross-resistance.  The characterization of those mutations is crit. for the development of second generation IN inhibitors to overcome resistance.  This review focuses on IN resistance based on structural and biochem. data, and on the role of the IN flexible loop i.e., between residues G140-G149 in drug action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzaFeDwbAmz7Vg90H21EOLACvtfcHk0ljLqpCIb6bSYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1anu70%253D&md5=f808e1a78587d971351107f9a4e9befa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3390%2Fv2071347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2071347%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DResistance%2520to%2520integrase%2520inhibitors%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26spage%3D1347%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span> </span><span class="NLM_article-title">Structural insights into the retroviral DNA integration apparatus</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1016%2Fj.sbi.2010.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=21277766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=249-256&author=P.+Cherepanovauthor=G.+N.+Maertensauthor=S.+Hare&title=Structural+insights+into+the+retroviral+DNA+integration+apparatus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the retroviral DNA integration apparatus</span></div><div class="casAuthors">Cherepanov, Peter; Maertens, Goedele N.; Hare, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Retroviral replication depends on successful integration of the viral genetic material into a host cell chromosome.  Virally encoded integrase, an enzyme from the DDE(D) nucleotidyltransferase superfamily, is responsible for the key DNA cutting and joining steps assocd. with this process.  Insights into the structural and mechanistic aspects of integration are directly relevant for the development of antiretroviral drugs.  Recent breakthroughs have led to biochem. and structural characterization of the principal integration intermediates revealing the tetramer of integrase that catalyzes insertion of both 3' viral DNA ends into a sharply bent target DNA.  This review discusses the mechanism of retroviral DNA integration and the mode of action of HIV-1 integrase strand transfer inhibitors in light of the recent visualization of the prototype foamy virus intasome, target DNA capture and strand transfer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt41KftkBkbVg90H21EOLACvtfcHk0ljLqpCIb6bSYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D&md5=b60c38e193175b2576a27b8a7a40ad80</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DMaertens%26aufirst%3DG.%2BN.%26aulast%3DHare%26aufirst%3DS.%26atitle%3DStructural%2520insights%2520into%2520the%2520retroviral%2520DNA%2520integration%2520apparatus%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Perryman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">A dynamic model of HIV integrase inhibition and drug resistance</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=600-615&author=A.+L.+Perrymanauthor=S.+Forliauthor=G.+M.+Morrisauthor=C.+Burtauthor=Y.+Chengauthor=M.+J.+Palmerauthor=K.+Whitbyauthor=J.+A.+McCammonauthor=C.+Phillipsauthor=A.+J.+Olson&title=A+dynamic+model+of+HIV+integrase+inhibition+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerryman%26aufirst%3DA.%2BL.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DA%2520dynamic%2520model%2520of%2520HIV%2520integrase%2520inhibition%2520and%2520drug%2520resistance%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D397%26spage%3D600%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Geretti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armenia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccherini-Silberstein, F.</span><span> </span><span class="NLM_article-title">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1097%2FQCO.0b013e32835a1de7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=23086187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=677-686&author=A.+M.+Gerettiauthor=D.+Armeniaauthor=F.+Ceccherini-Silberstein&title=Emerging+patterns+and+implications+of+HIV-1+integrase+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span></div><div class="casAuthors">Geretti, Anna Maria; Armenia, Daniele; Ceccherini-Silberstein, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent data on the pathways of resistance that impact the clin. activity of first-generation and second-generation integrase inhibitors.  Recent findings: Raltegravir (RAL) and elvitegravir (EVG) are highly efficacious in first-line antiretroviral therapy, with small nos. of virol. failures obsd. in clin. trials.  Durable activity in treatment-experienced patients requires a fully supportive background regimen.  RAL and EVG show a low-to-moderate genetic barrier to resistance and extensive cross-resistance, which preclude their sequential use.  Resistance to dolutegravir (DTG) is not selected as readily in vitro and has not emerged in studies of treatment-naive patients to date.  Both in vitro and in vivo, DTG retains activity against several RAL and EVG resistant strains, but susceptibility is variably impaired by multiple mutations within the G148 pathway, which are common after RAL or EVG failure.  Cross-resistance can be partially overcome by doubling DTG dosing to twice daily, but durability of responses remains dependent on a supportive background regimen.  There is variability in the integrase gene of circulating HIV strains, which does not appear to reduce drug activity, although it may influence the emergence and evolution of integrase resistance.  Transmission of integrase resistance remains rare but surveillance is required.  Summary: Integrase inhibitors provide a potent option for the treatment of HIV infection.  Drug resistance remains a challenge, which may be partially overcome by the introduction of second-generation compds.  Prompt management of RAL and EVG failure is required to prevent the accumulation of multiple resistance mutations that reduce DTG susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJNLh3j8EBULVg90H21EOLACvtfcHk0ljtcZJCeBcGxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE&md5=ad104b6dff368c146f9cef84a553506f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32835a1de7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32835a1de7%26sid%3Dliteratum%253Aachs%26aulast%3DGeretti%26aufirst%3DA.%2BM.%26aulast%3DArmenia%26aufirst%3DD.%26aulast%3DCeccherini-Silberstein%26aufirst%3DF.%26atitle%3DEmerging%2520patterns%2520and%2520implications%2520of%2520HIV-1%2520integrase%2520inhibitor%2520resistance%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D677%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span> </span><span class="NLM_article-title">Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=491-501&author=O.+Delelisauthor=S.+Thierryauthor=F.+Subraauthor=F.+Simonauthor=I.+Maletauthor=C.+Allouiauthor=S.+Sayonauthor=V.+Calvezauthor=E.+Deprezauthor=A.-G.+Marcelinauthor=L.+Tchertanovauthor=J.-F.+Mouscadet&title=Impact+of+Y143+HIV-1+integrase+mutations+on+resistance+to+raltegravir+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DThierry%26aufirst%3DS.%26aulast%3DSubra%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DAlloui%26aufirst%3DC.%26aulast%3DSayon%26aufirst%3DS.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26atitle%3DImpact%2520of%2520Y143%2520HIV-1%2520integrase%2520mutations%2520on%2520resistance%2520to%2520raltegravir%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D54%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Quashie, P. K.; Sloan, R. D.; Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Novel therapeutic strategies targeting HIV integrase</span>.  <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">34</span>), DOI: <span class="refDoi"> DOI: 10.1186/1741-7015-10-34</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1186%2F1741-7015-10-34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22498430" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&issue=34&author=P.+K.+Quashie&author=R.+D.+Sloan&author=M.+A.+Wainberg&title=Novel+therapeutic+strategies+targeting+HIV+integrase&doi=10.1186%2F1741-7015-10-34"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-34%26sid%3Dliteratum%253Aachs%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26atitle%3DNovel%2520therapeutic%2520strategies%2520targeting%2520HIV%2520integrase%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26issue%3D34%26doi%3D10.1186%2F1741-7015-10-34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span> </span><span class="NLM_article-title">Dolutegravir for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=523-530&author=C.+Katlamaauthor=R.+Murphy&title=Dolutegravir+for+the+treatment+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DDolutegravir%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D523%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ballantyne, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Dolutegravir: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1627-1637&author=A.+D.+Ballantyneauthor=C.+M.+Perry&title=Dolutegravir%3A+first+global+approval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DA.%2BD.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DDolutegravir%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D1627%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Vandeckerckhove, L.</span><span> </span><span class="NLM_article-title">GSK-1349572, a novel integrase inhibitor for the treatment of HIV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=203-212&author=L.+Vandeckerckhove&title=GSK-1349572%2C+a+novel+integrase+inhibitor+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVandeckerckhove%26aufirst%3DL.%26atitle%3DGSK-1349572%252C%2520a%2520novel%2520integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8735</span><span class="NLM_x">–</span> <span class="NLM_lpage">8744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8735%26epage%3D8744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikamiyama-Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles</span></div><div class="casAuthors">Kawasuji, Takashi; Johns, Brian A.; Yoshida, Hiroshi; Weatherhead, Jason G.; Akiyama, Toshiyuki; Taishi, Teruhiko; Taoda, Yoshiyuki; Mikamiyama-Iwata, Minako; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work is a continuation of our initial discovery of a potent monocyclic carbamoyl pyridone human immunodeficiency virus type-1 (HIV-1) integrase inhibitor that displayed favorable antiviral and pharmacokinetic properties.  We report herein a series of bicyclic carbamoylpyridone (I; satd. and unsatd. bridge; R = e.g., alkoxyethyl) analogs to address conformational issues from our initial SAR studies.  This modification of the core unit succeeded to deliver low nanomolar potency in std. antiviral assays.  An addnl. hydroxyl substituent on the bicyclic scaffold provides remarkable improvement of antiviral efficacies against clin. relevant resistant viruses.  These findings led to addnl. cyclic tethering of the naked hydroxyl group resulting in tricyclic carbamoyl pyridone inhibitors (II; Y = O, N; n = 0-2; R' = e.g., alkyl, Ac, methanesulfonyl) to address remaining issues and deliver potential clin. candidates.  The tricyclic carbamoyl pyridone derivs. described herein served as the immediate leads in mols. to the next generation integrase inhibitor dolutegravir which is currently in late stage clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLpPj5UB1TbVg90H21EOLACvtfcHk0lghgSjY8T8Lcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D&md5=4bfe919f8fdbbc84e346e3f01e084b70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1124%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Activities, crystal structures and molecular dynamics of dihydro-1<i>H</i>-isoindole derivatives, inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300471n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=209-217&author=M.+Metifiotauthor=K.+Maddaliauthor=B.+C.+Johnsonauthor=S.+Hareauthor=S.+J.+Smithauthor=X.+Z.+Zhaoauthor=C.+Marchandauthor=T.+R.+Burkeauthor=S.+H.+Hughesauthor=P.+Cherepanovauthor=Y.+Pommier&title=Activities%2C+crystal+structures+and+molecular+dynamics+of+dihydro-1H-isoindole+derivatives%2C+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb300471n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300471n%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BC.%26aulast%3DHare%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DActivities%252C%2520crystal%2520structures%2520and%2520molecular%2520dynamics%2520of%2520dihydro-1H-isoindole%2520derivatives%252C%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sangeetha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amutha, R.</span><span> </span><span class="NLM_article-title">Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors</span> <span class="citation_source-journal">SAR QSAR Environ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=753-771&author=B.+Sangeethaauthor=R.+Muthukumaranauthor=R.+Amutha&title=Pharmacophore+modelling+and+electronic+feature+analysis+of+hydroxamic+acid+derivatives%2C+the+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangeetha%26aufirst%3DB.%26aulast%3DMuthukumaran%26aufirst%3DR.%26aulast%3DAmutha%26aufirst%3DR.%26atitle%3DPharmacophore%2520modelling%2520and%2520electronic%2520feature%2520analysis%2520of%2520hydroxamic%2520acid%2520derivatives%252C%2520the%2520HIV%2520integrase%2520inhibitors%26jtitle%3DSAR%2520QSAR%2520Environ.%2520Res.%26date%3D2013%26volume%3D24%26spage%3D753%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">R, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7211</span><span class="NLM_x">–</span> <span class="NLM_lpage">7219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=D.+K.+Rauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+hydroxamic+acids+are+potent+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DR%26aufirst%3DD.%2BK.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520hydroxamic%2520acids%2520are%2520potent%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7211%26epage%3D7219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham Yuk, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2292</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1014378" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2282-2292&author=J.+Tangauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Sham+Yukauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=3-Hydroxypyrimidine-2%2C4-diones+as+an+inhibitor+scaffold+of+HIV+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm1014378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014378%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSham%2BYuk%26aufirst%3DY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D3-Hydroxypyrimidine-2%252C4-diones%2520as%2520an%2520inhibitor%2520scaffold%2520of%2520HIV%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2282%26epage%3D2292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahive, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel <i>N</i>-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200208d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3393-3417&author=T.+W.+Johnsonauthor=S.+P.+Tanisauthor=S.+L.+Butlerauthor=D.+Dalvieauthor=D.+M.+DeLisleauthor=K.+R.+Dressauthor=E.+J.+Flahiveauthor=Q.+Huauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=G.+A.+McClellanauthor=Q.+Pengauthor=M.+B.+Pleweauthor=P.+F.+Richardsonauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=X.+Yuauthor=J.+Zhangauthor=H.+Zhu&title=Design+and+synthesis+of+novel+N-hydroxy-dihydronaphthyridinones+as+potent+and+orally+bioavailable+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200208d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200208d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeLisle%26aufirst%3DD.%2BM.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DFlahive%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcClellan%26aufirst%3DG.%2BA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520N-hydroxy-dihydronaphthyridinones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3393%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Desimmie, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeulemeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taltynov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billamboz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelkov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotelle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span> </span><span class="NLM_article-title">2-Hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1194</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb4000426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1187-1194&author=B.+A.+Desimmieauthor=J.+Demeulemeesterauthor=V.+Suchaudauthor=O.+Taltynovauthor=M.+Billambozauthor=C.+Lionauthor=F.+Baillyauthor=S.+Strelkovauthor=Z.+Debyserauthor=P.+Cotelleauthor=F.+Christ&title=2-Hydroxyisoquinoline-1%2C3%282H%2C4H%29-diones+%28HIDs%29%2C+novel+inhibitors+of+HIV+integrase+with+a+high+barrier+to+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcb4000426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4000426%26sid%3Dliteratum%253Aachs%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DSuchaud%26aufirst%3DV.%26aulast%3DTaltynov%26aufirst%3DO.%26aulast%3DBillamboz%26aufirst%3DM.%26aulast%3DLion%26aufirst%3DC.%26aulast%3DBailly%26aufirst%3DF.%26aulast%3DStrelkov%26aufirst%3DS.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DCotelle%26aufirst%3DP.%26aulast%3DChrist%26aufirst%3DF.%26atitle%3D2-Hydroxyisoquinoline-1%252C3%25282H%252C4H%2529-diones%2520%2528HIDs%2529%252C%2520novel%2520inhibitors%2520of%2520HIV%2520integrase%2520with%2520a%2520high%2520barrier%2520to%2520resistance%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1187%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Billamboz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lion, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeulemeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreola, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotelle, P.</span><span> </span><span class="NLM_article-title">4-Substituted 2-hydroxyisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as a novel class of HIV-1 integrase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400009t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=606-611&author=M.+Billambozauthor=V.+Suchaudauthor=F.+Baillyauthor=C.+Lionauthor=J.+Demeulemeesterauthor=C.+Calmelsauthor=M.-L.+Andreolaauthor=F.+Christauthor=Z.+Debyserauthor=P.+Cotelle&title=4-Substituted+2-hydroxyisoquinoline-1%2C3%282H%2C4H%29-diones+as+a+novel+class+of+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml400009t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400009t%26sid%3Dliteratum%253Aachs%26aulast%3DBillamboz%26aufirst%3DM.%26aulast%3DSuchaud%26aufirst%3DV.%26aulast%3DBailly%26aufirst%3DF.%26aulast%3DLion%26aufirst%3DC.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DCalmels%26aufirst%3DC.%26aulast%3DAndreola%26aufirst%3DM.-L.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DCotelle%26aufirst%3DP.%26atitle%3D4-Substituted%25202-hydroxyisoquinoline-1%252C3%25282H%252C4H%2529-diones%2520as%2520a%2520novel%2520class%2520of%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D606%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stead, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bru, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, R. A.</span><span> </span><span class="NLM_article-title">Discovery of an HIV integrase inhibitor with an excellent resistance profile</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=709-719&author=D.+C.+Prydeauthor=R.+Websterauthor=S.+L.+Butlerauthor=E.+J.+Murrayauthor=K.+Whitbyauthor=C.+Pickfordauthor=M.+Westbyauthor=M.+J.+Palmerauthor=D.+J.+Bullauthor=H.+Vuongauthor=D.+C.+Blakemoreauthor=D.+Steadauthor=C.+Ashcroftauthor=I.+Gardnerauthor=C.+Bruauthor=W.-Y.+Cheungauthor=I.+O.+Robertsauthor=J.+Mortonauthor=R.+A.+Bissell&title=Discovery+of+an+HIV+integrase+inhibitor+with+an+excellent+resistance+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DBull%26aufirst%3DD.%2BJ.%26aulast%3DVuong%26aufirst%3DH.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAshcroft%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DBru%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DW.-Y.%26aulast%3DRoberts%26aufirst%3DI.%2BO.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DBissell%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520an%2520HIV%2520integrase%2520inhibitor%2520with%2520an%2520excellent%2520resistance%2520profile%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D709%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes Stephen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke Terrence, R.,  Jr.</span><span> </span><span class="NLM_article-title">Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-ones and 4,5-dihydroxy-1<i>H</i>-isoindole-1,3(2<i>H</i>)-diones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2714-2717&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=B.+C.+Vuauthor=C.+Marchandauthor=H.+Hughes+Stephenauthor=Y.+Pommierauthor=R.+Burke+Terrence&title=Examination+of+halogen+substituent+effects+on+HIV-1+integrase+inhibitors+derived+from+2%2C3-dihydro-6%2C7-dihydroxy-1H-isoindol-1-ones+and+4%2C5-dihydroxy-1H-isoindole-1%2C3%282H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%2BStephen%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%2BTerrence%26aufirst%3DR.%26atitle%3DExamination%2520of%2520halogen%2520substituent%2520effects%2520on%2520HIV-1%2520integrase%2520inhibitors%2520derived%2520from%25202%252C3-dihydro-6%252C7-dihydroxy-1H-isoindol-1-ones%2520and%25204%252C5-dihydroxy-1H-isoindole-1%252C3%25282H%2529-diones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2714%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghyn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R. F.</span><span> </span><span class="NLM_article-title">Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061169b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1322-1334&author=M.+Flipoauthor=T.+Beghynauthor=V.+Lerouxauthor=I.+Florentauthor=B.+P.+Deprezauthor=R.+F.+Deprez-Poulain&title=Novel+selective+inhibitors+of+the+zinc+plasmodial+aminopeptidase+PfA-M1+as+potential+antimalarial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</span></div><div class="casAuthors">Flipo, Marion; Beghyn, Terence; Leroux, Virginie; Florent, Isabelle; Deprez, Benoit P.; Deprez-Poulain, Rebecca F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1322-1334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteases that are expressed during the erythrocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria.  The authors report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite.  These compds. are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals.  Structure-activity relationships in these series are described.  Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1 (I).  This inhibitor displays good physicochem. and pharmacokinetic properties and a promising antimalarial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGZDfeX1vJmLVg90H21EOLACvtfcHk0lhqmUrpPEGf1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFKrs7s%253D&md5=4db507b62dc17d977d0ffd10eb4a74b6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061169b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061169b%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DBeghyn%26aufirst%3DT.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DDeprez%26aufirst%3DB.%2BP.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%2BF.%26atitle%3DNovel%2520selective%2520inhibitors%2520of%2520the%2520zinc%2520plasmodial%2520aminopeptidase%2520PfA-M1%2520as%2520potential%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1322%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nicolaou, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfefferkorn, J.</span><span> </span><span class="NLM_article-title">Synthesis of the tricyclic core of eleutherobin and sarcodictyins and total synthesis of sarcodictyin A</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">11353</span><span class="NLM_x">–</span> <span class="NLM_lpage">11354</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja973000g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=11353-11354&author=K.+C.+Nicolaouauthor=J.+Y.+Xuauthor=S.+Kimauthor=T.+Ohshimaauthor=S.+Hosokawaauthor=J.+Pfefferkorn&title=Synthesis+of+the+tricyclic+core+of+eleutherobin+and+sarcodictyins+and+total+synthesis+of+sarcodictyin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja973000g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja973000g%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DHosokawa%26aufirst%3DS.%26aulast%3DPfefferkorn%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520the%2520tricyclic%2520core%2520of%2520eleutherobin%2520and%2520sarcodictyins%2520and%2520total%2520synthesis%2520of%2520sarcodictyin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D11353%26epage%3D11354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rylander, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpenko, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pond, G. R.</span><span> </span><span class="NLM_article-title">Selectivity of hydrogenation over platinum metal catalysts: nitroaromatics</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1970&pages=266-275&author=P.+N.+Rylanderauthor=I.+M.+Karpenkoauthor=G.+R.+Pond&title=Selectivity+of+hydrogenation+over+platinum+metal+catalysts%3A+nitroaromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRylander%26aufirst%3DP.%2BN.%26aulast%3DKarpenko%26aufirst%3DI.%2BM.%26aulast%3DPond%26aufirst%3DG.%2BR.%26atitle%3DSelectivity%2520of%2520hydrogenation%2520over%2520platinum%2520metal%2520catalysts%253A%2520nitroaromatics%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1970%26volume%3D172%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Takenaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyosu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, H.</span><span> </span><span class="NLM_article-title">Selective synthesis of N-aryl hydroxylamines by the hydrogenation of nitroaromatics using supported platinum catalysts</span> <span class="citation_source-journal">Green Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1039%2Fb904672k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1385-1390&author=Y.+Takenakaauthor=T.+Kiyosuauthor=J.-C.+Choiauthor=T.+Sakakuraauthor=H.+Yasuda&title=Selective+synthesis+of+N-aryl+hydroxylamines+by+the+hydrogenation+of+nitroaromatics+using+supported+platinum+catalysts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Selective synthesis of N-aryl hydroxylamines by the hydrogenation of nitroaromatics using supported platinum catalysts</span></div><div class="casAuthors">Takenaka, Yasumasa; Kiyosu, Takahiro; Choi, Jun-Chul; Sakakura, Toshiyasu; Yasuda, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1385-1390</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Various substituted nitroaroms. were successfully hydrogenated to the corresponding N-aryl hydroxylamines in excellent yields (up to 99%) using supported platinum catalysts such as Pt/SiO2 under a hydrogen atm. (1 bar) at room temp.  The key to the fast and highly selective formation of hydroxylamines is the addn. of small amts. of amines such as triethylamine and DMSO; amines promote the conversion of nitroaroms., while DMSO inhibits further hydrogenation of hydroxylamines to anilines.  The promotive effect depends on which type of amine and primary amine was most effective.  The hydrogenation efficiently proceeded in common org. solvents, including isopropanol, di-Et ether, and acetone.  This methodol. should extend the application range of conventional solid catalysts to fine chems. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxpTvDQQKJ67Vg90H21EOLACvtfcHk0lg-zu0PhMwJyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtbjK&md5=903b72ed82c1b4a7171fed7cbfc305bf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fb904672k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904672k%26sid%3Dliteratum%253Aachs%26aulast%3DTakenaka%26aufirst%3DY.%26aulast%3DKiyosu%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DJ.-C.%26aulast%3DSakakura%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DH.%26atitle%3DSelective%2520synthesis%2520of%2520N-aryl%2520hydroxylamines%2520by%2520the%2520hydrogenation%2520of%2520nitroaromatics%2520using%2520supported%2520platinum%2520catalysts%26jtitle%3DGreen%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D1385%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 Integrase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7309</span><span class="NLM_x">–</span> <span class="NLM_lpage">7313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7309-7313&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=S.+J.+Smithauthor=M.+Metifiotauthor=B.+Johnsonauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=6%2C7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing+HIV-1+Integrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D6%252C7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing%2520HIV-1%2520Integrase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7309%26epage%3D7313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Williams, P. D.; Venkatraman, S.; Langford, H. M.; Kim, B.; Booth, T. M.; Grobler, J. A.; Staas, D.; Ruzek, R. D.; Embrey, M. W.; Wiscount, C. M.; Lyle, T. A.</span><span> </span><span class="NLM_article-title">Preparation of 1-Hydroxynaphthyridin-2(1<i>H</i>)-one Derivatives as Anti-HIV Agents</span>. Patent WO2008010964(A1).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Williams%2C+P.+D.%3B+Venkatraman%2C+S.%3B+Langford%2C+H.+M.%3B+Kim%2C+B.%3B+Booth%2C+T.+M.%3B+Grobler%2C+J.+A.%3B+Staas%2C+D.%3B+Ruzek%2C+R.+D.%3B+Embrey%2C+M.+W.%3B+Wiscount%2C+C.+M.%3B+Lyle%2C+T.+A.+Preparation+of+1-Hydroxynaphthyridin-2%281H%29-one+Derivatives+as+Anti-HIV+Agents.+Patent+WO2008010964%28A1%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%25201-Hydroxynaphthyridin-2%25281H%2529-one%2520Derivatives%2520as%2520Anti-HIV%2520Agents" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">2,3-Dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-one-based HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=251-259&author=X.+Z.+Zhaoauthor=E.+A.+Semenovaauthor=B.+C.+Vuauthor=K.+Maddaliauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=2%2C3-Dihydro-6%2C7-dihydroxy-1H-isoindol-1-one-based+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070715d%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSemenova%26aufirst%3DE.%2BA.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D2%252C3-Dihydro-6%252C7-dihydroxy-1H-isoindol-1-one-based%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valantin, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peytavin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span> </span><span class="NLM_article-title">Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1351-1358&author=I.+Maletauthor=O.+Delelisauthor=M.-A.+Valantinauthor=B.+Montesauthor=C.+Soulieauthor=M.+Wirdenauthor=L.+Tchertanovauthor=G.+Peytavinauthor=J.+Reynesauthor=J.-F.+Mouscadetauthor=C.+Katlamaauthor=V.+Calvezauthor=A.-G.+Marcelin&title=Mutations+associated+with+failure+of+raltegravir+treatment+affect+integrase+sensitivity+to+the+inhibitor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DValantin%26aufirst%3DM.-A.%26aulast%3DMontes%26aufirst%3DB.%26aulast%3DSoulie%26aufirst%3DC.%26aulast%3DWirden%26aufirst%3DM.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DPeytavin%26aufirst%3DG.%26aulast%3DReynes%26aufirst%3DJ.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26atitle%3DMutations%2520associated%2520with%2520failure%2520of%2520raltegravir%2520treatment%2520affect%2520integrase%2520sensitivity%2520to%2520the%2520inhibitor%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1351%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3715</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi100130f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3715-3722&author=M.+Metifiotauthor=K.+Maddaliauthor=A.+Naumovaauthor=X.+Zhangauthor=C.+Marchandauthor=Y.+Pommier&title=Biochemical+and+pharmacological+analyses+of+HIV-1+integrase+flexible+loop+mutants+resistant+to+raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi100130f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100130f%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DBiochemical%2520and%2520pharmacological%2520analyses%2520of%2520HIV-1%2520integrase%2520flexible%2520loop%2520mutants%2520resistant%2520to%2520raltegravir%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3715%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mesplede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quashie, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Resistance to HIV integrase inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1097%2FCOH.0b013e328356db89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22789986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=401-408&author=T.+Mespledeauthor=P.+K.+Quashieauthor=M.+A.+Wainberg&title=Resistance+to+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to HIV integrase inhibitors</span></div><div class="casAuthors">Mesplede, Thibault; Quashie, Peter K.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: HIV integrase inhibitors are potent antiretroviral drugs that efficiently decrease viral load in patients.  Emergence of resistance mutations against this new class of drugs represents a threat to their long-term efficacy.  The purpose of this review is to provide new information about the most recent mutations identified and other mutations that confer resistance to several integrase inhibitors.  Recent findings: New resistance mutations, such as G118R, R263K and S153Y, have been recently identified through in-vitro selection studies with second-generation integrase strand-transfer inhibitors (INSTIs).  These add to the three main resistance pathways involving mutations at positions Y143, N155 and Q148.  Structural modeling, biochem. analyses and deep sequencing are methods that currently help in the understanding of the mechanisms of resistance conferred by these mutations.  Although these new resistance mutations appear to confer only low levels of cross-resistance to second-generation drugs, the Q148 pathway with numerous secondary mutations has the potential to significantly decrease susceptibility to all drugs of the INSTI family.  Summary: Recent mutations selected in vitro with second-generation INSTIs suggest the existence of low levels of cross-resistance between these drugs and first-generation compds.  In clin. practice, the emergence of mutations at position Q148 should be monitored whenever possible.  More datasets are needed to assess the long-term efficacy of second-generation INSTIs in patients failing older INSTIs such as raltegravir and elvitegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsULhoKhjr9bVg90H21EOLACvtfcHk0lh2KmyFBYMYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO&md5=aea851c3b23668be783f7584cb9e9507</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e328356db89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e328356db89%26sid%3Dliteratum%253Aachs%26aulast%3DMesplede%26aufirst%3DT.%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DResistance%2520to%2520HIV%2520integrase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2012%26volume%3D7%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Bicyclic hydroxy-1<i>H</i>-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1111%2Fj.1747-0285.2011.01270.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=22107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=157-165&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=M.+Metifiotauthor=S.+J.+Smithauthor=B.+C.+Vuauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=Bicyclic+hydroxy-1H-pyrrolopyridine-trione+containing+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span></div><div class="casAuthors">Zhao, Xue Zhi; Maddali, Kasthuraiah; Metifiot, Mathieu; Smith, Steven J.; Vu, B. Christie; Marchand, Christophe; Hughes, Stephen H.; Pommier, Yves; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 integrase (IN) is a validated therapeutic target for the treatment of AIDS.  However, the emergence of resistance to raltegravir, the sole marketed FDA-approved IN inhibitor, emphasizes the need to develop second-generation inhibitors that retain efficacy against clin. relevant IN mutants.  We report herein bicyclic hydroxy-1H-pyrrolopyridinetriones as a new family of HIV-1 integrase inhibitors that were efficiently prepd. using a key "Pummerer cyclization deprotonation cycloaddn." cascade of imidosulfoxides.  In in vitro HIV-1 integrase assays, the analogs showed low micromolar inhibitory potencies with selectivity for strand transfer reactions as compared with 3'-processing inhibition.  A representative chlorofluorobenzyl hydroxypyrrolopyridinetrione retained most of its inhibitory potency against the three major raltegravir-resistant IN mutant enzymes, G140S/Q148H, Y143R, and N155H.  In antiviral assays employing viral vectors coding these IN mutants, the chlorofluorobenzyl hydroxypyrrolopyridinetrione was approx. 200- and 20-fold less affected than raltegravir against the G140S/Q148H and Y143R mutations, resp.  The representative chlorofluorobenzyl hydroxypyrrolopyridinetrione was affected approx. 10-fold less by the N155H mutation than raltegravir.  Hydroxypyrrolopyridinetriones are a novel structural class that may be further optimized to obtain HIV-1 integrase inhibitors capable of overcoming raltegravir resistance in HIV-1 strains possessing G140S/Q148H mutations in HIV-1 integrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-V1xazfn1LVg90H21EOLACvtfcHk0lh2KmyFBYMYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D&md5=467e940ff1b737e55486e8f578db6da0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01270.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01270.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DBicyclic%2520hydroxy-1H-pyrrolopyridine-trione%2520containing%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Brachmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldbruegge, M.</span><span> </span><span class="NLM_article-title">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span> <span class="citation_source-journal">Mol. Genet. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401902n&amp;key=10.1007%2Fs00438-004-1067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401902n&amp;key=15316769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401902n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2004&pages=216-226&author=A.+Brachmannauthor=J.+Koenigauthor=C.+Juliusauthor=M.+Feldbruegge&title=A+reverse+genetic+approach+for+generating+gene+replacement+mutants+in+Ustilago+maydis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span></div><div class="casAuthors">Brachmann, A.; Koenig, J.; Julius, C.; Feldbruegge, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-226</span>CODEN:
                <span class="NLM_cas:coden">MGGOAA</span>;
        ISSN:<span class="NLM_cas:issn">1617-4615</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We describe a versatile strategy for generating gene replacement mutants in the phytopathogenic fungus Ustilago maydis.  The system includes the choice of 32 different insertion cassettes for genetic engineering purposes, such as gene disruption and more sophisticated insertions of reporter genes, heterologous promoters or combinations of the two.  PCR-amplified flanking sequences needed for homologous recombination are ligated to the resp. insertion cassettes via Sfi I sites.  As proof of principle we generated two replacement mutants in which the endogenous promoter of the pheromone gene mfa1 drives expression of the Green Fluorescent Protein gene (gfp).  Simultaneously, expression of the mfa1 ORF is controlled either by the carbon source-regulated crg1 promoter or the nitrogen source-regulated nar1 promoter.  In both cases gfp expression was pheromone-inducible and pheromone expression was only detected when the heterologous promoters were active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckY_KQd6m37Vg90H21EOLACvtfcHk0lh2KmyFBYMYBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D&md5=ae76faf1e45e14ef570b2cf60e8d67a3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00438-004-1067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00438-004-1067-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrachmann%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DJ.%26aulast%3DJulius%26aufirst%3DC.%26aulast%3DFeldbruegge%26aufirst%3DM.%26atitle%3DA%2520reverse%2520genetic%2520approach%2520for%2520generating%2520gene%2520replacement%2520mutants%2520in%2520Ustilago%2520maydis%26jtitle%3DMol.%2520Genet.%2520Genomics%26date%3D2004%26volume%3D272%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401902n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401902n%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401902n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                550KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799870bae56d94a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
